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ABSTRACT 
Intravenous self-administration of drugs by experi-
mental animals has importance as a laboratory model for the 
study of drug abuse and for the investigation of the neuro-
chemical mechanisms underlying the reinforcing properties 
of drugs. Utilizing the drug self-administration technique, 
pharmacological investigations of the neurochemical basis 
of drug reinforcement suggest that opiate reinforcement is 
mediated through activation of central noradrenergic sys-
tems, whereas the reinforcing effects of psychomotor stimu-
lants are mediated via activation of dopaminergic systems. 
The major purpose of the present study was to determine if 
the alpha noradrenergic receptor agonist, clonidine, would 
be self-administered by rats and furthermore to determine 
if clonidine is self-administered for its positive reinforc-
ing effects. The latter was investigated by increasing the 
response requirement to obtain each clonidine injection. 
In view of the opiate-like effects of clonidine, the ability 
of clonidine to maintain self-administration behavior in 
rats self-administering the synthetic narcotic fentanyl was 
investigated. Also, the effect of response-contingent 
naloxone injections on clonidine-reinforced responding were 
compared with; their effect on fentanyl-reinforced respond-
ing. Since stimulation of the noradrenergic system is sug-
gested to be involved in mediating the reinforcing effects 
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of opiates, preliminary experiments compared the character-
istics of clonidine-reinforced responding with the character-
istics of f entanyl-reinf orced responding by independently 
adding selected butyrophenones to the clonidine and fentanyl 
solutions. Under pentobarbital anesthesia male hooded rats 
of the Long-Evans strain were implanted with chronic indwell-
ing jugular catheters and allowed to self-administer either 
clonidine (15 ug/Kg/injection), fentanyl (O.l and 1.0 
ug/Kg/injection) or saline on a continuous reinforcement 
schedule. The drug solutions were delivered, in a constant 
volume of 100 ul/Kg, into the vein in less than one second. 
Subjects readily acquired the self-administration of cloni-
dine and fentanyl (1 ug/Kg/injection) but not fentanyl 
(0.1 ug/Kg/injection) nor saline. Stable rates of clonidine 
and fentanyl-reinforced responding were attained after 3 or 
5 days, respectively. When the fixed ratio (FR) requirement 
to obtain each clonidine injection was increased from 1 to 
3, a significant increase in lever pressing was observed; 
however, total daily clonidine intake decreased significantly. 
When the FR requirement was further increased from 3 to 10, 
response rate increased so that total daily clonidine intake 
at the FR-3 and FR-10 schedules of clonidine reinforcement 
remained the same. Substitution of clonidine (15 ug/Kg/ 
injection but not clonidine (1 ug/Kg/injection) nor saline 
maintained self-administration behavior in rats previously 
self-administering fentanyl. Extinction of self-administration 
iii 
behavior was observed following the substitution of both 
clonidine (1 ug/Kg/injection) and saline for the fentanyl 
solution. Addition of naloxone (64 ug/Kg/injection) to the 
clonidine and fentanyl solutions significantly decreased 
fentanyl-reinforced responding but appeared to have no ef-
fect on clonidine-reinforced responding. Fentanyl rein-
forced responding returned to pre-naloxone rates following 
the removal of naloxone from the fentanyl solution. Addi-
tion of either haloperidol or azaperone to the clonidine and 
fentanyl solutionsiso that the subjects received 64 ug/Kg/ 
injection,. tended to decrease the rates of self-administra-
tion of rats previously self-administering either clonidine 
or fentanyl alone. Removal of haloperidol and azaperone 
from the clonidine and fentanyl solutions tended to result 
in a return to pre-haloperidol and pre-azaperone response 
rates. Addition of aceperone (64 ug/Kg/injection) produced 
no significant change in the rate of clonidine-reinforced 
responding but resulted in a significant increase in the 
rate of fentanyl-reinforced responding. Self-administration 
of clonidine by rats suggests that stimulation of central 
alpha-noradrenergic receptors results in positive reinforce-
ment. Clonidine's self-administration by rats and its 
ability to maintain self-administration behavior in rats 
previously self-administering fentanyl suggests this drug 
may have abuse potential. Preliminary experiments suggest 
some similarities between clonidine- and fentanyl-reinforced 
iv 
responding; however, the exact nature of these similari-
ties remain to be determined. The reinforcing effects of 
clonidine, unlike the reinforcing effects of fentanyl, 
seem to be mediated by opioid independent mechanisms. 
v 
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INTRODUCTION 
Intravenous self-administration of drugs by experi-
mental animals has importance as both a laboratory model 
for experimental addiction and for the study of the neuro-
chemical mechanisms underlying the reinforcing property of 
drugs. Utilizing the drug self-administration technique 
it has been established that drugs of several pharmaco-
logical classes which are abused by humans for their posi-
tive reinforcing effects are also self-administered by ex-
perimental animals (Seiden and Dykstra, 1977). The exact 
nature of the reinforcing effects of drugs is unclear but 
several investigations have suggested that catecholaminer-
gic brain mechanisms are involved in mediating the posi-
tive reinforcing effects of opiates and psychomotor 
stimulants (Pickens et al., 1968; Davis and Smith, 1972, 
1973a, 1973b, 1974, 1975; Pozuello and Kerr, 1972; Glick 
et al., 1973; Baxter et al., 1974; Davis et al., 1975; 
Yokel and Wise, 1975, 1976; Wilson and Schuster, 1972, 1974). 
Early experiments demonstrated that the catecholamine 
synthesis inhibitor, alpha-methyl-para-tyrosine, blocked 
the primary reinforcing action of morphine and psychomotor 
stimulant drugs (Pickens et al., 1968; Davis and Smith, 
1972, 1973; Pozuello and Kerr, 1972; Glick et al., 1973). 
It was also reported that alpha-methyl-para-tyrosine pre-
vented the establishment of conditioned reinforcement based 
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on the primary reinforcing properties of morphine and 
d-amphetamine suggesting that the effect of alpha-methyl-
para-tyrosine was not due to a non-specific motor deficit 
(Davis and Smith, 1973a, 1973b). In addition, Jonsson 
et al., (1969, 1971) reported that alpha-methyl-para- tyro-
sine blocked those subjective effects of d-amphetamine in 
man which are considered related to its positive reinforc-
ing effects. Furthermore, Wilson and Schuster (1972) 
demonstrated that the catecholamine receptor blocker, chlor-
promazine, antagonized the positive reinforcing effects of 
cocaine and other psychomotor stimulant compounds in rats. 
Based on the above reports it was suggested that stim-
ulation of catecholaminergic mechanisms of the brain under-
lie the positive reinforcing properties of opiates and 
psychomotor stimulants. However, because brain levels of 
both dopamine and norepinephrine are depleted by alpha-
methyl-para-tyrosine and both dopaminergic and noradrener-
gic receptors are blocked by chlorpromazine, the exact role 
r for each catecholamine in mediating the positive reinforc-
ing effects of opiates and psychomotor stimulants remained 
unclear. 
Investigations attempting to differentiate between 
dopaminergic and noradrenergic mechanisms utilized drugs 
which selectively depleted brain norepinephrine but not 
dopamine (Davis and Smith, 1974; Davis et al., 1975) are 
selectively blocked dopaminergic but not noradrenergic re-
ceptors (or vice versa) (Smith and Davis, 1973; Davis and 
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Smith, 1974, 1975; Yokel and Wise, 1975, 1976). Utilizing 
the dopamine beta hydroxylase inhibitors, diethyldithio-
carbamate (DDC) and U-14,624, to selectively deplete brain 
norepinephrine, Davis and Smith (1974) and Davis et al. 
(1975) reported that DDC and U-14,624 inhibited the primary 
reinforcing action of morphine while U-14,624 inhibited the 
primary reinforcing action of a-amphetamine. Furthermore, 
DDC or U-14,624 pretreatment prevented the establishment 
of a conditioned reinforcer based on primary reinforcement 
associated with morphine and a-amphetamine injections 
(Davis and Smith, 1974; Davis et al., 1975). 
These data suggested that the reinforcing properties 
of morphine and d-amphetamine are mediated by noradrenergic 
and not dopaminergic brain mechanisms. However, while 
other studies provided further support that noradrenergic 
mechanisms and not dopaminergic mechanisms are important 
in mediating the reinforcing effects of morphine (Davis and 
Smith, 1973, 1974, 1975) it appeared that dopaminergic and 
not noradrenergic systems are important in mediating the 
reinforcing effects of a-amphetamine (Davis and Smith, 
1975; Yokel and Wise, 1975, 1976). 
Smith and Davis (1973,1974) concluded that prevention 
of reacquisition of morphine-reinforced responding by the 
dopamine receptor blocking agent haloperidol was due to a 
motor deficit produced by this drug and was not due to its 
ability to block the reinforcing effects produced by morphine 
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self-administration. This conclusion was supported by the 
finding that haloperidol did not block the establishment 
of a morphine-based conditioned reinforcer (Smith and Davis, 
1973, 1974). Therefore based on this evidence and the study 
of Davis et al. (1975) the reinforcing property of morphine 
seems to depend on noradrenergic and not dopaminergic mech-
anism in the brain. 
On the other hand, Davis and Smith (1975) reported that 
haloperidol blocked the primary reinforcing effects of 
d-amphetamine and prevented the establishment of a condi-
tioned reinforcer based on d-amphetamine as a primary rein-
forcer. These data suggested that haloperidol can block the 
reinforcing action of d-amphetamine without producing motor 
deficits. Similarly, Yokel and Wise (1975, 1976) reported 
that the dopamine receptor blockers pimozide and (+)-buta-
clamol blocked the reinforcing effects produced by d-amphet-
amine self-administration in rats. In a clinical study, 
Gunne et al. (1972) reported that pimozide reduced amphet-
amine euphoria in humans. 
Additional support for a role of dopamine but not 
norepinephrine in the reinforcing action of psychomotor 
stimulants was provided by Wilson and Schuster (1974) who 
demonstrated that the alpha-noradrenergic receptor blocker, 
phentolamine, had no effect on cocaine self-administration. 
Furthermore, Yokel and Wise (1975, 1976) demonstrated that 
the alpha-noradrenergic receptor blocker phenoxybenzamine 
had no effect on a-amphetamine self-administration while 
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decreased rates of d-amphetamine self-administration pro~ 
duced by phentolamine and the beta-adrenergic receptor 
blocker propranolol were due to actions other than reward 
attenuation. Thus several studies suggest that dopamine 
is an important mediator of the reinforcing effects of 
psychomotor stimulants. That direct stimulation of dopa-
mine receptors can result in positive reinforcement was 
demonstrated by the finding that rats will self-administer 
the dopamine receptor agonist apomorphine (Baxter et al., 
1974). 
In conclusion the reinforcing property of opiates ap-
pear to depend on noradrenergic mechanisms (Smith and 
Davis, 1973, 1974, 1975; Davis et al., 1975) whereas the 
reinforcing actions of psychomotor stimulants appear to 
depend on dopaminergic mechanisms (Davis and Smith, 1975; 
Yokel and Wise, 1975, 1976). Furthermore, self-administra-
tion of the dopamine receptor agonist apomorphine demon-
strates that stimulation of central dopamine receptors 
results in positive reinforcement (Baxter et al., 1974). 
The major purpose of the present experiment was to 
investigate if rats will self-administer the alpha-nor-
adrenergic receptor agonist (Anden et al., 1970), clonidine. 
It was hypothesized that clonidine would be self-adminis-
tered by rats since it had been previously reported (Smith 
and Davis, 1975) that the reinforcing properties of opiates 
are mediated through activation of noradrenergic mechanisms 
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in the brain. It was also of interest to determine if 
clonidine was self-administered for its positive reinforc-
ing effects and not because of the drug's direct behavioral 
effects. This was accomplished by increasing the response 
requirement to obtain each clonidine injection. Self-
administration rates to obtain morphine (Weeks, 1962) and 
psychomotor stimulants (Pickens, 1968; Pickens and Harris, 
1968; Pickens and Thompson, 1968; Goldberg et al., 197lc) 
increase as the response requirement to obtain these drugs 
is increased, therefore, it was hypothesized that if clon-
idine was self-administered for its positive reinforcing 
effects self-administration rates to obtain clonidine 
injections would increase as the response requirement to 
obtain clonidine injections was increased. 
Fentanyl is a synthetic narcotic which is known to be 
self-administered by rats (Lal et al., 1977). Since the 
noradrenergic system seems to be involved in mediating nar-
cotic reinforcement (Davis and Smith, 1973, 1974, 1975), 
preliminary experiments compared the characteristics of 
fentanyl-reinforced responding with the characteristics of 
clonidine-reinforced responding. For this purpose three 
different butyrophenone neuroleptics with differential 
potencies versus dopaminergic and noradrenergic receptors 
were added to the clonidine and f entanyl solutions for self-
administra tion of the drug mixture. The effect of the 
butyrophenones on clonidine-reinforced responding were 
compared to their effect on fentanyl-reinforced responding. 
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The butyrophenones were added to the clonidine and f entanyl 
solutions for self-administration of the drug mixture since 
the effect of intraperitoneal administration of these drugs 
was already known. Furthermore, this procedure may have 
potential for the treatment of drug abuse since concomitant 
administration of an antagonist with the reinforcing ago-
nist should result in extinction of the drug-seeking be-
havior. Because butyrophenone' beuroleptics decrease·nor-
adrenergic transmission and narcotic r~inforcement depends 
on activation of noradrenergic mechanisms, it was hypothe-
sized that addition of the butyrophenones to the clonidine 
and fentanyl solutions would result in decreased rates of 
clonidine- and fentanyl-reinforced responding. 
Finally, it has been demonstrated that clonidine and 
opiates have similar actions on noradrenergic neurons 
(Redmond, 1977) and produce similar pharmacological ef-
fects such as inhibition of narcotic withdrawal (Tseng et 
al., 1975; Vetulani and Bednarczyk, 1977; Fielding et al., 
1977, in press; Gold et al., 1978) and analgesia (Paalzow, 
1974; Paalzow and Paalzow, 1976; Schmitt et al., 1974; 
Sewell and Spencer, 1975; Fielding et al., 1977, in press; 
Bentley et al., 1977). In view of these similarities the 
ability of clonidine to maintain fentanyl-reinforced re-
sponding was investigated by substituting clonidine for 
the f entanyl solution. It was hypothesized that clonidine 
would maintain the previously established self-administra-
tion behavior. 
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All actions of narcotics, including their positive re-
inforcing action (Goldberg et al., 1972) and their ability 
to impart secondary reinforcing properties on previously 
neutral stimuli (Davis and Smith, 1974a; Marcus et al., 
1976), are antagonized by the narcotic antagonist naloxone. 
In contrast, however, the pharmacological actions of cloni-
dine which are similar to those produced by narcotics are 
not antagonized by naloxone suggesting that these actions 
of clonidine occur through opioid independent mechanisms 
(Paalzow and Paalzow, 1976; Fielding et al., 1977, in press; 
Meyer et al., 1977; Washton et al., 1978). A preliminary 
experiment was performed to determine the effect of adding 
naloxone to the clonidine and fentanyl solutions for self-
administration of the drug mixture. The effect of naloxone 
on clonidine-reinforced responding was compared to its ef-
fect on fentanyl-reinforced responding to determine if 
clonidine reinforcement is mediated via opioid dependent 
mechanisms. It was hypothesized that naloxone would de-
crease fentanyl- but not clonidine-reinforced responding. 
8 
LITERATURE REVIEW 
CLONIDINE: ITS ACTIONS ON CENTRAL NEUROTRANSMITTER SYSTEMS 
A. Clonidine and the Central Noradrenergic System 
Clonidine (2-(2,6-dichlorophenylamino-2-imidazoline 
hydrochloride) is a very potent antihypertensive drug 
(Nickerson and Ruedy, 1975) which can stimulate peripher-
al alpha-adrenergic receptors (Boissier et al., 1968; 
Constantine and Mcshane, 1968). However, the antihyperten-
sive action of clonidine appears to be mediated by alpha-
adrenergic stimulatory activity at alpha-adrenergic recep-
tors within the medulla oblongata (Kobinger and Walland, 
1967; Schmitt and Schmitt, 1970; Van Zwieten, 1975) which 
are inhibitory to sympathetic nerve stimulation, thereby 
reducing sympathetic outflow from the vasomotor center of 
the medulla. 
Studies on the central noradrenergic system show that 
clonidine reduces the turnover rate of norepinephrine in 
whole brain (Anden et al., 1970) and some of its regions 
(Rochette et al., 1974) as measured by a slowing of the 
disappearance of this amine following synthesis inhibition 
with the tyrosine hydroxylase inhibitor, alpha-methyl-para-
tyrosine. This effect was counteracted by pretreatment 
with the alpha-noradrenergic receptor blocking agents halo-
peridol and phenoxybenzamine (Anden et al., 1970), thus sug-
westing a post-synaptic noradrenergic receptor stimulating 
action of clonidine. 
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Clonidine has also been found to reduce the rate of 
formation of norepinephrine from labelled tyrosine (Rochette 
et al., 1974) and lower brain levels of the maj.or norepine-
phrine metabolite 3-methoxy-4-hydroxy-phenylglycol (MOPEG) 
(Braestrup, 1974). 
Whole brain levels of norepinephrine are not changed 
by low (30 or 400 ug/Kg) doses of clonidine (Anden et al .. , 
1970). However, higher doses (0.5-2.5 mg/kg) produce a 
significant increase in norepinephrine levels in all brain 
regions except the striatum (Laverty and Taylor, 1969). 
Radioisotope studies indicated an increase in norepinephrine 
storage without significant changes in metabolism. 
Clonidine was found to diminish the stimulation-evoked 
tritum overflow from rat cerebral cortical slices preincu-
bated with tritrated noradrenaline (Farnebo and Hamberger, 
1971; Starke and Montel, 1973) and abolish the increase in 
tritium overflow produced by phenoxybenzamine and phentol-
amine (Farnebo and Hamberger, 1971; Starke and Mantel, 1973) 
but not cocaine (Starke and Montel, 1973). Since phenoxy-
benzamine and phentolamine block alpha-noradrenergic recep-
tors while cocaine primarily blocks the reuptake of norepine-
phrine it was conlcuded that clonidine stimulates alpha-
receptors. 
Although the latter experiments and those of Anden et 
al. (1970, 1976) suggest that clonidine stimulates central 
post-synaptic alpha-noradrenergic receptors, some post-
synaptic alpha-noradrenergic receptors appear to be inhibited 
10 
by the drug. While clonidine has no significant effect on 
basal levels of cyclic 3',5' adenosine monophosphate in in-
cubated slices of rat cerebral cortex (Skolnick and Daly, 
1975a) it antagonized the norepinephrine elicited accumula-
tion of cyclic AMP to a degree which corresponds to the 
alpha adrenergic component of the norepinephrine response. 
Clonidine also completely blocked the increase in cyclic 
AMP produced by methoxamine (Skolnick and Daly, 1975b), an 
alpha adrenergic agonist. However, clonidine did not atten-
uate the accumulation of cyclic AMP elicited by maximal 
concentrations of the beta adrenergic agonist, isoprotero-
nol, and markedly potentiated the effects of submaximal 
concentration of this agent (Skolnick and Daly, 1975a) . The 
locus of clonidine's action appears to be post-synaptic 
since destruction of pre-synaptic noradrenergic terminals 
with 6-hydroxydopamine had no effect on the norepinephrine 
and isoproteronol induced accumulation of cyclic AMP 
(Skolnick and Daly, 1976). Furthermore, the results of 
Skolnick and Daly (1975a) suggest that clonidine may sensi-
tize the beta-adrenergic receptor. 
In addition to its action on central post-synaptic 
noradrenergic receptors, clonidine also stimulates pre-
synaptic noradrenergic receptors. Svensson et al. (1975) 
demonstrated that clonidine, administered intravenously or 
applied microiontophoretically, inhibited the spontaneous 
firing of brain norepinephrine containing neurons (Dahlstrom 
and Fuxe, 1965) in the locus coeruleus. These findings 
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suggest that neurons in the locus coer~leus possess pre-
synaptic alpha-adrenergic receptors located on or near their 
soma and that activation of these receptor sites by cloni-
dine may be responsible for its ability to inhibit the 
activity of these noradrenergic neurons. Further support 
for a ~resynaptic noradrenergic receptor stimulation by 
clonidine was provided by Cedarbaum and Aghajanian (1976) 
who found that the presynaptic alpha-noradrenergic receptor 
blocker (Cubeddu et al., 1974), piperoxane, blocked the 
clonidine-induced inhibition of firing of locus coeruleus 
neurons. 
B. Clonidine and the Central Serotoninergic System 
Clonidine has been found to affect the central sero-
toninergic system. The majority of evidence indicates that 
clonidine's effect on this system is indirect and probably 
occurs via central noradrenergic neurons. However, a direct 
action of clonidine on the central serotoninergic system 
cannot be ruled out. 
Anden et al. (1970) found that clonidine reduced the 
turnover rate of serotonin as measured by a slowing of the 
disappearance of this amine in rat brain after synthesis 
inhibition with the tryptophan hydroxylase inhibitior alpha-
propylacetaminde. This effect was counteracted by pretreat-
ment with the noradrenergic receptor blocking agents phenoxy-
benzamine and haloperidol suggesting that noradrenergic 
receptor stimulation directly or indirectly inhibits the 
12 
activity of serotonin neurons. Similar reductions in the 
turnover of serotonin in whole brain and some of its regions 
were observed by Scheel-Kruger and Hasselager (1974) and 
Rochette and Bralet (1975). 
Although clonidine does not affect whole brain levels 
of serotonin in rats and mice (Anden et al., 1970; Maj et 
al., 1973) it markedly elevates the serotonin content of 
the pons plus medulla (Maj et al., 1973), a region rich in 
serotonin neurons (Dahlstrom and Fuxe, 1965). Furthermore, 
decreased whole brain levels of serotonin produced by L-dopa 
were prevented by clonidine (Maj et al., 1973). 
Apomorphine and L-dopa induced elevation of brain con-
centrations of the serotonin metabolite, 5-hydroxyindole-
acetic acid (5-HIAA) was antagonized by clonidine although 
clonidine by itself did not affect 5-HIAA levels (Maj et al., 
1973). However, when measured at a different time follow-
ing clonidine administration Scheel-Kruger and Hasselager 
(1974) reported that clonidine produced a significant de-
crease in the concentration of 5-HIAA. These findings sug-
gest that clonidine may inhibit the release of serotonin. 
Following blockade of central noradrenergic receptors 
by haloperidol or phenoxybenazamine, Anden et al. (1970) 
found that clonidine did not produce effects on spinal re-
flexes similar to those observed after treatment with 5-hy-
droxytryptophan indicating that clonidine has no direct 
stimulating action on cerebral serotonin receptors like 
LSD (Anden et al., 1968). 
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Utilizing single cell recording techniques,Svensson 
et al. (1975) investigated the effect of clonidine on the 
firing rate of serotonin neurons. When administered intra-
venously clonidine inhibited the firing rate of a great 
majority of serotonin neurons in the midbrain dorsal raphe 
nucleus. However, this action did not seem to be a direct 
one since clonidine had relatively weak or variable effects 
when applied microiontophoretically to raphe neurons. These 
findings suggest that clonidine-induced depression of raphe 
firing may be secondary to an impairment in noradrenergic 
transmission as prior destruction of noradrenergic neurons 
by 6-hydroxydopamine rendered the raphe neurons insensitive 
to the depressant effect of intravenous clonidine. Also 
much higher doses of clonidine, which have been reported to 
have post-synaptic receptor activity (Anden et al., 1970), 
reversed the depression produced by a low dose of clonidine 
itself. 
C. Clonidine and the Central Dopaminergic System 
The effect of clonidine on the central dopaminergic sys-
tem is not well documented, however, investigations study-
ing this interaction demonstrate in general that clonidine 
has no effect on the central dopaminrgic system. 
Anden et al. (1970) measured the effect of clonidine on 
the turnover rate of dopamine in rat brain as measured by 
disappearance of this amine following synthesis inhibition 
with the tyrosine hydroxylase inhibitior alpha-methyl-para-
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tyrosine and found that clonidine had little or no effect. 
It was also demonstrated that clonidine did not change 
levels of dopamine in whole brain. 
Treatment with reserpine plus the dopamine precursor 
L-dopa, produces turning to the operated side in rats with 
a unilateral lesion of the corpus striatum (Anden et al., 
1966). However, no turning to the operated side was ob-
served in rats with one intact corpus striatum after treat-
ment with reserpine plus clonidine, indicating that cloni-
dine has no stimulating effect on central dopamine receptors 
(Anden et al., 1970). 
Clonidine had no effect on dopaminergic neuronal firing 
when applied microiontophoretically to dopaminergic neuronal 
soma in the substantia nigra (zona compacta) and adjacent 
medial ventral tegmentum; however, apomorphine inhibited 
dopaminergic neuronal firing (Aghajanian and Bunney ,1977). 
These findings also suggest a lack of dopaminergic receptor 
stimulation by clonidine. 
D. Clonidine and O~er Central Transmitter Systems 
Recent evidence suggests that clonidine may have ef-
fects on other central neurotransmitter systems. 
Maj et al. (1975) reported that atropine and scopol-
amine block clonidine-induced decreases in locomotor ac-
tivity of rats, indicating a possible cholinergic mechanism 
of action. It was also found that clonidine increased the 
acetylcholine concentration in rats' striatum but did not 
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influence its content in cortex, hypothalamus, thalamus, 
pons or medulla oblangata (Maj et al., 1975). 
The possible involvement of central histamine H2-
receptors in mediating hhe hypotensive effect of clonidine 
has recently been demonstrated (Karppanen, 1976). Further-
more, it was found that histamine, clonidine or norepine-
phrine decreased the firing rate of cerebral cortical 
neurons, when applied microiontophoretically (Sastry and 
Phyllis, 1977). Metiamide, an H2-histamine receptor antag-
onist, reversed the depressant effects of clonidine and 
histamine but not norepinephrine. These results suggest 
that clonidine can activate histamine H2-receptors on cen-
tral neurons. 
PSYCHOPHARMACOLOGICAL ACTIONS OF CLONIDINE 
~. Motor Behavior 
1. Rotorod Test 
Rotorod performance is measured by the ability of 
an animal to stay on a revolving drum or cylinder over a 
period of time. Clonidine (1.0 mg/Kg, i.p.) reduced roto-
rod performance in rats (Laverty and Taylor, 1969) and 
mice (EDso 0.24 mg/Kg, s.c.) (Cornfeldt et al., 1978). 
2. Open Field and Hole Test 
In the open field and hole test, clonidine (0.1 
mg/Kg) was reported to potentiate the depressant effect 
on rats behavior produced by intracerebroventricular admin-
istration of 6-hydroxy-dopamine (Herman et al., 1976). 
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3. Locomotor Activity 
Locomotor activity has been suggested to be con-
trolled by both the dopaminergic and noradrenergic system 
within the brain (Anden et al., 1976). Locomotor activity 
in laboratory animals is often measured by the number of 
times the subject interrupts a light beam in a photocell 
chamber (Seiden and Dykstra, 1977). Each time the light 
beam is interrupted a count is recorded and thus the num-
ber of counts varies proportionately with the subject's 
locomotor activity. 
When measured in the above manner, clonidine (0.05-
25.0 mg/Kg) has been reported to produce a dose-dependent 
decrease in the locomotor activity of mice and rats (Maj 
et al., 1972, 1975; Tilson et al., 1977) in spite of marked 
sympathomimetic signs (Maj et al., 1972). 
While clonidine (1-25 mg/Kg) potentiated the decrease 
in locomotor activity in mice produced by pretreatment with 
the neuroleptic, spiroperidol (Maj et al., 1972), it did 
not influence the depression of locomotor activity produced 
by pretreatment with reserpine (Anden et al., 1970a, 1973, 
1976; Maj et al., 1972; Menon et al., 1977), alpha-methyl-
para-tyrosine (Anden et al., 1972; Maj et al., 1972), FLA-
63 or phenoxybenzamine (Maj et al., 1972) despite marked 
sympathomimetic signs. However, clonidine (1-25 mg/Kg) po-
tentiated the partial reversal of locomotor activity pro-
duced by apomorphine in mice pretreated with reserpine 
(Anden et al., 1970a, 1973, 1976; Jenner and Pycock, 1976; 
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Maj et al., 1972; Menon et al., 1977), alpha-methyl-para-
tyrosine (Anden et al., 1970a, Maj et al. , 1972) and FLA-63 
(Maj et al., 1972) at doses which do not interfere with 
the metabolism of apomorphine (Anden et al . , 1973). Further-
more, increased locomotor activity induced by the dopamine 
receptor stimulant metatyrosine (Anden et al., 1973) or LSD 
(Menon et al., 1977) in reserpine treated mice was enhanced 
by clonidine (1.0 mg/Kg, i.p.) pretreatment. Clonidine 
(5 and 25 mg/Kg) did not potentiate the antagonism of phenoxy-
benzamine induced decrease in locomotor activity produced by 
apomorphine, but resulted in a decreased effect of apomor-
phine (Maj et al., 1972). The potentiation by clonidine of 
the apomorphine-induced locomotor stimulation in reserpine-
treated mice was almost completely blocked by phenoxybenza-
mine (20 mg/Kg), partially antagonized by tolazoline (50 
mg/Kg) and not significantly affected by yohimbine (3 and 
10 mg/Kg) (Anden et al., 1976). 
Locomotor activity decreased by clonidine in mice and 
rats was antagonized by atropine and scopolamine (Maj et al., 
1975). The peripheral cholinolytics atropine methyl nitrate 
and scopolamine butyl bromide were ineffective in mice and 
partly effective in rats in antagonizing the clonidine-
induced decrease in locomotor activity · (Maj et al., 1975). 
In conclusion, these studies demonstrate that clonidine 
produces a dose-dependent decrease in the locomotor activity 
of both mice and rats. However, clonidine may potentiate 
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the increased locomotor activity produced by other drugs 
under certain pharmacological conditions. Results of stu-
dies investigating the mechanism by which clonidine affects 
locomotor activity suggest the involvement of cholinergic 
(Maj et al., 1975) and noradrenergic (Anden et al., 1976) 
mechanisms. These studies also strengthen the suggestion 
of Maj et al., 1972 that stimulation of both dopaminergic 
and noradrenergic systems are required for maximal loco-
motor activity. 
4. Circling 
Circling or rotational behavior in rats with uni-
lateral lesions of the nigrostriatal pathway is considered 
to be a dopamine dependent behavior. This consideration 
is based upon the finding that administration of drugs which 
increase dopaminergic activity in the central nervous sys-
tem after the lesion produce rotational behavior (Ungerstedt 
et al., 1969). 
Using a rotometer which measures the number of full 
turns the subject makes per unit time, Satoh et al., 1976 
reported that, in rats with unilateral 6-hydroxydopamine-
induced lesions of the substania nigra, intraventricular 
injection of apomorphine, dopamine and norepinephrine at 
doses of 64 ug induced turning of the rats towards the in-
tact side whereas intraventricular injection of methamphet-
amine (250 ug) induced turning towards the lesioned side. 
On the other hand, intraventricular injection of clonidine 
(64 ug) did not induce any turning. It was suggested by 
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Satoh et al. that dopamine, norepinephrine and apomorphine 
directly stimulate the supersensitive dopamine receptors on 
the side of the lesion whereas methamphetamine indirectly 
stimulates dopamine receptors on the intact side. Since 
clonidine is considered to be an alpha-noradrenergic ago-
nist (Anden et al., 1970), norepinephrine-induced turning 
was considered to be due to a non-specific stimulation of 
dopamine receptors. 
Direct injection of clonidine (100 ug) into one stri-
atum of rats with intact nigrostriatal systems did not pro-
duce circling, nor did this pretreatment result in circling 
following the subcutaneous administration of the dopamine 
agonist apomorphine (0.5 mg/Kg) (Jenner and Pycock, 1976). 
However, circling behavior induced by either apomorphine 
(0.25 mg/Kg, s.c.) or d-amphetamine (3 mg/Kg, i.p.) in mice 
with unilateral lesions of the nigriostriatal pathway was 
potentiated by pretreatment with clonidine (0.06-2.0 mg/Kg, 
i.p.) (Jenner and Pycock, 1976; Pycock et al., 1977). In 
contrast to this latter finding, Cornfeldt et al., 1978 
reported that clonidine (ED50 0.08 mg/Kg, i.p.) blocked 
amphetamine- but not apomorphine-induced circling in rats 
with striatal lesions. 
Unilateral electrolytic destruction of the locus 
coeruleus in rats results in spontaneous ipsilateral turn-
ing behavior which is soon replaced by contralateral turn-
ing (Pycock et al., 1975). One week after locus coeruleus 
lesioning, when spontaneous turning has stopped, intraperi-
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toneal administration of the dopamine agonists apomorphine, 
d-amphetamine and piribedil but not the noradrenergic ago-
nist, clonidine (0.05-0.5 mg/Kg) elicited contralateral 
circling (Donaldson et al., 1977). It was suggested by 
Donaldson et al., that circling behavior seen after unilat-
eral locus coeruleus lesions was the result of supersensi-
tive striatal dopamine receptors in the nigrostriatal path-
way on the side of the lesion. 
The results of the above studies investigating the 
effect of clonidine on rotational behavior suggest that 
clonidine does not stimulate dopamine receptors and provides 
further evidence that rotational behavior depends on dopa-
minergic and not noradrenergic mechanisms. However, it 
appears rotational behavior induced by dopaminergic ago-
nists may be modified by clonidine (Jenner and Pycock, 1976; 
Pycock et al., 1977). 
5. Stereotypy 
Stereotypic behavior consists of the repeated spon-
taneous occurrence of motor responses which are within the 
animal's normal behavior such as licking, sniffing, gnawing 
and head bobbing (Seiden and Dykstra, 1977). Stereotypic 
behavior is believed to be the result of heightened dopa-
rninergic activity in the corpus striatum (Seiden and Dykstra, 
1977) . Both direct and indirect dopaminergic agonists such 
as apomorphine and d-amphetarnine, elicit stereotypic be-
havior (Seiden and Dykstra, 1977) . 
21 
Intraperitoneal administration of clonidine (0.5 mg/Kg) 
did not affect the stereotyped behavior induced by apomor-
phine (0.1-5.0 mg/Kg, s.c.) in rats (Jenner and Pycock, 1976; 
Pycock et al., 1977) suggesting that clonidine does not stim-
ulate striatal dopamine receptors. 
6. Catalepsy 
Catalepsy is generally defined as the condition of 
an animal when it is amenable to being positioned in awkward 
positions by an experimenter and where these postures are 
m~intained until altered by the experimenter (Rech and Moore, 
1971). Catalepsy may be caused by decreased dopaminergic 
activity within the nigrostriatal system (Seiden and Dykstra, 
1977). Neuroleptic drugs, such as haloperidol, which de-
crease dopaminergic activity induce catalepsy (Rech and 
Moore, 19 71) • 
Clonidine (0.5 mg/Kg, i.p.) has been reported to poten-
tiate the cataleptic action of haloperidol (0.1-2.0 mg/Kg, 
i.p.) in rats; however, this action is probably non-specific 
and is the result of clonidine's sedative effect (Jenner and 
Pycock, 1976; Pycock et al., 1977). 
7. Tremor-like Motor Dysfunctions (wet-shakes) 
"Wet dog shakes" in rats have been suggested to be 
due to heat gain mechanisms (Wei et al., 1974). Clonidine 
has been reported to inhibit the "wet dog shakes" produced 
in rats by immersion in ice-cold water (Wei, 1975) or by 
administration of the drug AG-3-5[1-(2-hydroxyphenyl)-4-
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(3-nitrophenyl)-1,2,3,6 tetrahydropyrimidine-2-one] (Wei, 
1976). Jahn and Mixich (1976) reported that clonidine 
(0.01-0.1 mg/Kg, s.c.) produced a dose-dependent reduction 
of "wet dog shakes" produced by the benzylideneaminooxy-
carbonic acid derivative Sgd 8473. The ability of clonidine 
to reduce "wet dog shakes" may be non-specific since several 
other drugs including narcotics, narcotic antagonists, psy-
chosedatives, cocaine, dl-amphetamine and apomorphine were 
also effective in this regard (Jahn and Mixich, 1976) . 
B. Operant Behavior 
1. Schedule Control 
Clonidine (0.006-.3 mg/Kg) produced a dose-depend-
ent suppression of operant behavior maintained by fixed-
ratio (Colelli et al., 1976), fixed-interval (Harris et al., 
1977) and differential reinforcement of low rates (Tilson 
et al., 1977) schedules of food-reinforced responding. 
When chronically administered, tolerance to the be-
havioral depressant effect of clonidine on food-reinforced 
responding was evident after 5 days and was complete by 2 
weeks (Meyer et al., 1977). Abrupt termination of clonidine 
treatment in tolerant rats resulted in an abstinence reac-
tion characterized by suppression of operant behavior for 
as long as one week (Meyer et al., 1977). 
Clonidine antagonized the disruption of fixed-ratio 
operant behavior produced by naloxone injection in morphine-
dependent rats (Colelli et al., 1976). 
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Whereas the rate decreasing effect of apomorphine un-
der a fixed-interval schedule of food reinforcement was 
potentiated by naloxone, the effect of clonidine was unal-
tered ~Harris et al., 1977). At doses capable of suppress-
ing operant behavior in morphine-dependent rats (Gellert 
and Sparber, 1977), naloxone failed to disrupt operant be-
havior in clonidine tolerant rats (Meyer et al., 1977). 
Suppression of fixed-ratio food-reinforced operant 
behavior in rats produced by depletion of brain catechola-
mines with alpha-methyl-para-~yrosine or tetrabenzaine was 
not antagonized by apomorphine or clonidine; however, L-dopa 
reversed the suppression produced by alpha-methyl-para-
tyrosine but not tetrabenazine (Ahlenius et al., 1971). 
In rats trained to respond on a fixed-interval schedule 
• 
of water-reinforced responding, Glick and Cox (1976) re-
ported that both apomorphine (0.25-10.0 mg/Kg) and clonidine 
(0.002-0.l mg/Kg) produced a dose-dependent suppression of 
responding. Following frontal cortical lesions the sensi-
tivity to apomorphine but not clonidine was increased 
(Glick and Cox, 1976). 
Intraventricular administration of 1-norepinephrine 
(10 ug), but not clonidine (0.5 ug), restored the dose-
related decrease in the rate of substania nigra self-stimula-
tion produced by norepinephrine synthesis inhibition with 
diethyldithiocarbamate (Belluzi et al., 1975). 
In summary, these findings indicate that clonidine 
produces a suppression of operant behavior maintained by 
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different schedules of food reinforced responding and by a 
fixed-interval schedule of water-reinforced responding. Be-
cause clonidine also reduces food intake (Le Douarec et al., 
1972), water intake (Le Douarec, 1971) and locomotor ac-
tivity (Tilson et al., 1977) in rats it cannot be stated 
with certainty whether clonidine suppresses operant behavior 
for food and water reinforcement because of its anorexic and 
adipsic effect or its sedative effect. Since a reduction in 
operant behavior is observed following a reduction in nor-
adrenergic transmission (Belluzi et al., 1975) the suppres-
sant effect of clonidine on operant behavior may be related 
to its stimulatory action at pre-synaptic alpha-adrenergic 
receptors, thus reducing noradrenergic transmission. This 
is supported by the finding that norepinephrine but not 
clonidine (Belluzi et al., 1975) will restore operant be-
havior suppressed by norepinephrine, synthesis inhibition. 
Finally, the suppressant action of clonidine on operant re-
sponding appears to be independent of an action on endoge-
nous opioid mechanisms since naloxone fails to alter the 
effect of clonidine (Harris et al., 1977; Gellert and 
Sparber, 1977). 
2. Conditioned Avoidance Response 
In the conditioned avoidance response (CAR) paradigm 
animals are trained to avoid an aversive stimulus by respond-
ing during a stimulus which precedes the delivery of the 
aversive stimulus (Seiden and Dykstra, 1977). Animals thus 
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trained become conditioned to avoid the aversive stimulus 
by responding during the pre-aversive stimulus signal. If 
the subject responds during the aversive stimulus it is 
considered to have ·escaped the aversive stimulus. Both 
dopamine and norpinephrine are considered to be involved in 
the mediation of an avoidance response (for review see 
Seiden and Dyks'tra, 1977). Neuroleptic drugs selectively 
disrupt avoidance responding at doses which do not disrupt 
escape (for review see Seiden and Dykstra, 1977). 
Laverty and Taylor (1969) reported that intraperiton-
eal administration of clonidine (0.1-1.0 mg/Kg), in rats 
trained to climb a pole to avoid a shock, produced a dose-
dependent inhibition of conditioned avoidance behavior. 
This may be a non-specific effect, however, and may be the 
result of sedation since these doses have been reported to 
decrease locomotor activity (Maj et al., 1972, 1975; Tilson 
et al., 1977). 
Depletion of brain catecholamines by 6-hydroxydopamine 
has been demonstrated to interfere with the maintenance and 
acquisition of avoidance responding (for review see Seiden 
and Dykstra, 1977) • Suppression of a previously learned 
conditioned avoidance response in rats produced by intra-
ventricular administration of 6-hydroxydopamine was reported 
to be reversed by intraventricular administration of nore-
pinephrine, dopamine, L-dopa or by intraperitoneal adminis-
tration of amphetamine, phenylzine, desipramine, apomorphine 
and clonidine (Ruiz and Monti, 1975; Lenard and Beer, 1975). 
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Pretreatment with the neuroleptic, spiroperidol, prevented 
the recovery produced by the above drugs, however, clonidine-
induced recovery was least affected (Lenard and Beer, 1975). 
The above studies demonstrate an effect of clonidine 
on conditioned avoidance responding and support the sugges-
tion for the involvement of both dopaminergic and noradren-
ergic systems in its mediation. 
3. Brain Self-Stimulation 
It is well established that laboratory animals will 
lever press to obtain electrical stimulation when electrodes 
are placed in various brain areas. Investigations of the 
neurochemical mechanisms underlying the reinforcing proper-
ty of intracranial self-stimulation(ICSS) suggest the 
possible involvement of both dopaminergic and noradrenergic 
systems (for review see Seiden and Dykstra, 1977). However, 
it has recently been reported that a stronger case can be 
made for the involvement of dopaminergic mechanisms (for 
review see Fibiger, 1978). 
Utilizing a shuttle-box technique that provides a 
rate-independent index of the rewarding and aversivecompo-
nents of ICSS, Hunt et al. (1976) reported that intraperi-
toneal administration of clonidine (.004-.063 mg/Kg) pro-
duced a dose-dependent increase in the latency to initiate 
lateral hypothalamic ICSS, whereas the latency to escape 
ICSS was largely unaffected except at doses which caused 
depression of performance. The peripheral alpha-adrenergic 
27 
agonist 1-phenylephrine (0.05-1.0 mg/Kg) was ineffective in 
this regard indicating that inhibition of reward by clonidine 
was a central effect (Hunt et al., 1976). Clonidine acted 
in a synergistic manner with the catecholamine synthesis in-
hibitor, alpha-methyl-para-tyrosine (250 mg/Kg) to greatly 
increase (~500%) the initiate latency magnitude and prolong 
the duration of inhibition of reward while leaving the es-
cape latency magnitude largely unaffected (Hunt et al., 
1976). Whereas administration of clonidine (0.016-0.064 
mg/Kg) or alpha-methyl-para-tyrosine alone 24 hours before 
testing had no effect, when given together they produced a 
complete elimination of the initiate behavior while escape 
behavior remained unaffected (Hunt et al., 1976). 
High rates of lateral hypothalamic ICSS in squirrel 
monkeys were blocked by clonidine (0.1 mg/Kg), whereas in 
the same animal caudate ICSS was much less affected at this 
dose (Spencer and Revzin, 1976). A higher dose of clonidine 
(0.25 mg/Kg) which produced sedation depressed ICSS equally 
well at both sites (Spencer and Revzin, 1976). In contrast, 
amphetamine (10 mg/Kg) and chlorpromazine (0.5 or 1.0 mg/Kg) 
had significantly more effect on caudate ICSS than lateral 
hypothalamic ICSS (Spencer and Revzin, 1976). 
Depression of lateral hypothalamic ICSS produced by 
clonidine (0.15 mg/Kg) was antagonized by doses of piperox-
ane (1.7-15.0 mg/Kg) which selectively block pre-synaptic 
alpha adrenergic or adrenaline-receptors while a higher dose 
of piperoxane (45 mg/Kg), phentolamine (0.55-15.0 mg/Kg) and 
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phenoxybenzamine (0.1-10.0 mg/Kg) which block both pre- and 
post-synaptic receptors were ineffective (Franklin and 
Herberg, 1977). 
At doses not producing motor deficits, Vetulani et al. 
(1977) reported that intraperitoneal administration of clon-
idine (0.05-.20 mg/Kg) in rats produced a dose-dependent 
depression of medial forebrain bundle ICSS. Furthermore, 
clonidine (0.10 mg/Kg) blocked the facilitation of medial 
forebrain bundle ICSS produced by d-amphetamine (0.5 mg/Kg) 
(Vetulani et al., 1977). Since ~-amphetamine has been re-
ported to release norepinephrine it was suggested that clon-
idine' s blockade of medial forebrain bundle ICSS was the 
result of its stimulatory action at pre-synaptic alpha-
noradrenergic receptors or its blockade of post-synaptic 
noradrenergic receptors (Vetulani et al., 1977). 
Based on the results of the above experiments demon-
strating a depression of ICSS by clonidfueit is not surpris-
ing that inhibition of substania nigra ICSS in rats produced 
by the norepinephrine synthesis inhibitors, diethyldithio-
carbamate (Belluzi et al., 1975) or inhibition of lateral 
hypothalamic ICSS by the norepinephrine synthesis inhibitor, 
disulfiram (Shaw and Rolls, 1976) was not restored by cloni-
dine (0.5-3 ug, i.v.t. or 0.037-3 mg/Kg, i.p.). 
In conclusion these findings suggest that clonidine 
attenuates the rewarding component of ICSS. Furthermore, 
this action appears to be mediated through its stimulatory 
action at central pre-synaptic alpha-noradrenergic receptors 
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thus decreasing noradrenergic transmission (Hunt et al., 
1976; Franklin and Herberg, 1977; Vetulani et al., 1977). 
This suggestion is supported by other investigations (Wise 
et al., 1973; Hastings and Stutz, 1943; Franklin and Herberg, 
1974; German and Bowden, 1974; Belluzi et al., 1975; Shaw 
and Rolls, 1976), which demonstrate that reduced noradrener-
gic transmission inhibits self-stimulation. It must be 
noted, however, that although inhibition of ICSS is reported 
at doses which do not produce motor deficits the same doses 
are reported to decrease locomotor activity when measured 
in an activity chamber (Tilson et al., 1977). 
4. Conflict-induced Suppression 
The Geller conflict procedure consists of a punish-
ment component and a non-punished component (Seiden and 
Dykstra, 1977). During the punishment component of this 
procedure, punishment (usually an electric grid shock) is 
superimposed on behavior (usually lever pressing for food 
reward) whereas during the non-punished component no punish-
ment is superimposed. Behavior is usually reduced during 
the punished component. Anxiolytic drugs increase behavior 
which has been suppressed by punishment (for review see 
Seiden and Dykstra, 1977), and therefore the Geller conflict 
procedure is widely used as a screening test for possible 
anxiolytic agents. 
Bullock et al. (1978), reported that intraperitoneal 
administration of clonidine (0.025-0.10 mg/Kg) in rats 
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produced a significant increase in responding during the 
punishment component of the Geller conflict procedure while 
responding during the non-punished component was relatively 
unaffected except at the highest dose (0.1 mg/Kg) where 
sedation was observed. These data suggest a possible anxio-
lytic action of clonidine. 
C. Aggressive Behavior 
It has been suggested that central catecholamines and sero-
tonin are involved in the mediation of aggressive behavior 
(for review see Seiden and Dykstra, 1977). Ozawa et al. 
(1975) reported that clonidine (40 mg/Kg) induced aggres-
sive behavior in mice without altering the levels of brain 
serotonin, norepinephrine or dopamine. In contrast, how-
ever, Razzak et al., 1977 reported that a large dose of 
clonidine, which induced automutilation in mice, markedly 
increased brain norepinephrine; slightly increased brain 
dopamine levels and did not change cerebral serotonin levels. 
The results of these studies suggest further investigation 
of the effect of clonidine on cerebral neurotransmitter 
levels and their turnover in relationship to aggression 
induced by this drug. 
Morpurgo (1968) first reported that intraperitoneal 
administration of high doses (10 and 50 mg/Kg) of clonidine 
induced aggression (biting attacks) in mice but not rats 
nor rabbits. This behavior was also produced when clonidine 
was administered orally, intravenously or subcutaneously. 
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Intracerebral injection of a 0.5% solution of clonidine 
irmnediately elicited biting attacks (Morpurgo, 1968). 
Other imidazoline derivatives (naphazoline, oxymetazo-
line), with similar peripheral sympathomimetic effects as 
clonidine did not induce biting even when administered in-
tracerebrally (Morpurgo, 1968). This is particularly in-
teresting in view of the finding that the imidazoline deriv-
atives, including naphazoline and oxymetazoline, which do 
not cross the blood-brain barrier produce analgesia when 
administered intracerebroventricularly (Schmitt et al., 
1974). 
Pretreatment with neuroleptic drugs (e.g. haloperidol 
ED 50 1.6 mg/Kg) inhibited the occurrence of clonidine-in-
duced biting attacks. However, pretreatment with the alpha-
adrenergic blocking agent, phentolamine, or the anti-cho-
linergic drug, atropine, were ineffective in preventing the 
occurrence of aggressive behavior (Morpurgo, 1968). Since 
the sympathomimetic effects of clonidine were still evident 
following neuroleptic pretreatment, the findings of Morpurgo 
(1968) suggested that clonidine-induced aggression in mice 
is independent of its alpha-adrenergic action. 
In contrast, however, Ozawa et al. (1975) reported 
that aggressive behavior in mice induced by intraperitoneal 
administration of clonidine (40 mg/Kg) was markedly inhibited 
by intraperitoneal pretreatment with the alpha-blocking 
agent phenoxybenzamine (20 mg/Kg). Similarly, Razzak et al. 
(1977) reported that automutilation induced by a large dose 
of clonidine was inhibited by reserpine, alpha-methyl-para-
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tyrosine, phenoxybenzamine, phentolamine or chlorpromazine 
pretreatment. 
Pretreatment with amytriptyline, PCPA, L-dopa, 5-HTP 
or glycine had no effect on the clonidine-induced aggression 
and self-mutilation (Ozawa et al., 1975; Stern and Catovic, 
1975; Razzak et al., 1977). 
Aggression and automutilation induced by clonidine was 
reported to be potentiated by disulfarim, lithium chloride 
(Ozawa et al., 1975); nalorphine, mephenesin (Stern and 
Catovic, 1975); methamphetamine, caffeine and theophylline 
(Razzak et al., 1977). 
These results suggest therefore, that central noradren-
ergic mechanisms are involved in the mediation of aggression 
and automutilation induced by clonidine. 
In rats aggression can be induced by sufficiently high 
doses of the dopaminergic agonist, apomorphine (McKenzie, 
1971) or by termination of chronic narcotic administration 
(Lal, 1975). It has been suggested that both of these forms 
of aggression are due to hyperstimulation of dopaminergic 
neurons in the central nervous system (Lal, 1975; Lal et al., 
1975). Clonidine by itself at doses of 0.25 and 0.5 mg/Kg 
administration subcutaneously did not produce aggression in 
drug-naive rats; however it dose-dependently (0.0625-0.25 
mg/Kg) enhanced aggression produced by a sub-threshold (for 
aggression) dose (2.5 mg/Kg) of apomorphine and enhanced 
aggression when administered to 72 hour morphine-withdrawn 
rats (Gianutsos et al., 1976). 
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It has also been reported that irritability and vio-
lent aggressive behavior occurs in rats following chronic 
treatment with clonidine (Laverty and Taylor, 1969) and 
that rats become irritable and aggressive while receiving 
clonidine (5 ug/ml) in their drinking water (Dix and 
Johnson, 19 77). 
While all of the previously cited studies suggest that 
clonidine may act to promote aggressive behavior in mice 
and rats, Laverty and Taylor (1969) reported that subcutan-
eous administration of clonidine (0.2-1.0 mg/Kg) produced 
a dose dependent inhibition of pain-induced aggressive be-
havior produced by application of electric shocks to the 
grid floor of a cage in which a pair of rats were placed 
and Cornfeldt et al. (1978) reported that clonidine (ED50 
3.8 mg/Kg p.o.) inhibited foot-shock induced aggression in 
mice. However, clonidine is known to produce analgesia 
(see Analgesia section) as measured by an increase in the 
threshold for vocalization (Paalzow, 1974; Schmitt et al., 
1974) and vocalization after discharge (Paalzow, 1974; 
Paalzow and Paalzow, 1976) following electrical stimulation 
of the rat's tail, and several other procedures. There-
fore, clonidine-induced inhibition of pain-induced fighting 
(produced by electrical shock application to the grid floor) 
may be the result of its analgesic action and not the re-
sult of its ability to modulate aggressive behavior. 
In conclusion it has been demonstrated that clonidine 
may promote, inhibit or have no effect on aggressive behavior. 
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Clonidine's action on aggressive behavior appears to depend 
on several factors including species, dose, treatment regi-
men (acute vs. chronic) and method of inducing aggression. 
Aggressive behavior produced by clonidine appears to be de-
pendent on both dopaminergic and noradrenergic brain mechanisms. 
D. Drug Self-Administration 
Drugs of several pharmacological classes are self-
administered for their positive reinforcing properties (for 
review see Seiden and Dykstra, 1977). Investigations of 
the neurochemical basis of reinforcement resulting from the 
self-administration of narcotics (Davis and Smith, 1972, 
1973a; Glick et al., 1973) and psychomotor stimulants (Davis 
and Smith, 1972, 1973b) have implicated the involvement of 
central catecholaminergic systems (for review see Seiden 
and Dykstra, 1977) . Attempts to differentiate between nor-
adrenergic and dopaminergic mechanism suggest the involve-
ment of noradrenergic mechanisms in opiate reinforcement 
(Davis et al., 1975) while both dopaminergic and noradren-
ergic mechanisms appear to be involved in psychomotor 
stimulant reinforcement (Davis et al., 1975; Davis and 
Smith, 19 7 5) • 
Bavis and Smith (1977) reported that clonidine (15 
but not 1 ug/Kg/injection) was self-administered by rats 
when this drug was made contingent on lever pressing. It 
w~s suggested that the reinforcing action of clonidine was 
the result of its stimulatory action at post-synaptic 
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alpha-noradrenergic receptors since intraperitoneal pretreat-
ment with the alpha-blocking agent phenoxybenzamine (15 
mg/Kg) prevented the reinforcement associated with clonidine 
administration (Davis and Smith, 1977). Furthermore, intra-
peritoneal pretreatment with phenoxybenzamine (15 mg/Kg) but 
not haloperidol (5 mg/Kg) prevented the establishment of a 
stimulus paired with injections of clonidine as a conditioned 
reinforcer (Davis and Smith, 1977). These results suggest 
that stimulation of alpha-noradrenergic receptors by cloni-
dine results in positive reinforcement. 
In rats self-administering the synthetic narcotic 
fentanyl (1 ug/Kg injection), Shearman et al. (1977) re-
ported that substitution of clonidine (15 but not 1 ug/Kg/ 
injection) for the fentanyl solution maintained self-
administration behavior. Since activation of noradrenergic 
systems is considered to be involved in the mediation of 
narcotic reinforcement (Davis, 1975), the maintenance of 
f entanyl-reinforced responding by clonidine may be the re-
sult of its ability to stimulate central noradrenergic re-
ceptors. 
E. Drug Discrimination 
It is now widely established that drugs of several 
pharmacological classes can function as discriminative 
stimuli (for review see Lal, 1977) • Usually in these ex-
periments laboratory animals are trained to emit one re-
sponse when treated with a drug and an alternate response 
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when treated with the drug vehicle, another dose of the 
same drug or a different drug. When acquisition of such 
response differentiation is reliably shown the drug is 
said to produce a discriminative stimulus that controls 
the differential responding in the trained subjects. 
In rats trained to discriminate morphine (10 mg/Kg) 
from saline, Miksic et al. (in press) reported that intra-
peritoneal administration of clonidine (0.08-0.64 mg/Kg) 
produced saline lever selection. Since the discriminative 
stimulus produced by morphine is considered to be related 
to its subjective effect in man (Lal and Gianutsos, 1976; 
Lal et al., 1977), this data suggests that clonidine and 
morphine may produce dissimilar subjective effects. In 
view of the fact that clonidine produces analgesia (see 
Analgesia section) and reduces narcotic withdrawal symp-
toms in animals and humans (see Antiwithdrawal section), 
this data becomes particularly interesting for it suggests 
that clonidine may provide a non-narcotic treatment for 
opiate addiction. 
F. Learning and Memory 
While an important role fur each of the central neuro-
transmitters in learning and memory processes has been post-
ulated (for review see Seiden and Dykstra, 1977), the exact 
role of each remains unclear. Furthermore, studies measur-
ing the effect of pharmacological agents on learning and 
memory processes must be interpreted with caution since 
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factors unrelated to their effect on learning and memory 
(i.e., sedation, impairment of motor function) can affect 
' the results. 
Gazzani and Izqueirdo (1976) reported that post-trial 
intraperitoneal administration of clonidine (O.l mg/Kg) or 
haloperidol (0.5 mg/Kg) to rats trained in a shuttle avoid-
ance paradigm resulted in a lower retention of this task in 
a retest session carried out seven days later compared to 
animals which received a post-trial saline injection. This 
effect of clonidine was prevented by pretreatment with 
either phenoxybenzamine (10 mg/Kg) or phentolamine (10 mg/Kg) 
whereas the effect of haloperidol was prevented by apomor-
phine (4 mg/Kg; but not 0.5 mg/Kg) pretreatment. These data 
suggest that clonidine may impair memory consolidation. 
In contrast to the above study, however, McEntee and 
Mair (1978) reported that administration of clonidine to 
Korsakoff syndrome patients (who had low CSF MHPG levels 
which correlated with memory impairment) resulted in a con-
sistent improvement of memory function. Since clonidine is 
a presumed alpha-noradrenergic agonist in the central nervous 
system, improvement of memory by clonidine (McEntee and Mair, 
1978), provides additional evidence for an important role 
of norepinephrine in learning and memory processes. 
G. Arousal Mechanisms 
Investigations of the neurochemical mechanisms underly-
ing arousal processes suggest that involvement of both 
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serotonin and catecholamines (for review see Seiden and 
Dykstra, 1977). 
Clonidine has been reported to produce sedation and 
sleep when administered via several routes to young chicks, 
rats, cats, rabbits and man (Zamis, 1970; Holman et al., 
1971; Florio et al., 1975; Marley and Nistico, 1975; Walland, 
1977). Given intravenously clonidine-induced sleep is in-
distinguishable from normal sleep or that elicited by intra-
venous noradrenaline or adrenaline (Holman et al., 1971). 
Behavioral depression and EEG synchronization induced 
by clonidine (0.1 mg/Kg) in rats, cats and rabbits were at-
tenuated by pretreatment with the alpha-noradrenergic re-
ceptor blocking agents phentolamine (10 mg/Kg) , tolazoline 
(10 mg/Kg) and yohimbine (0.5 mg/Kg) but not phenoxybenza-
mine (10 mg/Kg) (Florio et al., 1975). Similarly, Holman 
et al. (1971) and Delbarre and Schmitt (1971) noted that 
--
the sedative effect of clonidine was antagonized by phentol-
amine. Whereas pretreatment with the serotonin receptor 
antagonist methysergide or the serotonin synthesis inhibitor 
failed to prevent the sleep-inducing effect of clonidine, 
LSD pretreatment effectively prevented the sleep-producing 
effect of clonidine (Holman et al., 1971). Pretreatment 
with alpha-methyl-para-tyrosine ester· ( 100 mg/Kg, 3 days) 
or reserpine (2 mg/Kg) potentiated the clonidine (0.1 mg/Kg)-
induced sedation and EEG synchronization (Florio et al., 
1975). 
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Amphetamine (1 or 2 mg/Kg) reversed the behavioral de-
pression and EEG synchronization produced by clonidine 
(0.2 mg/Kg) (Florio et al., 1975). Furthermore, clonidine 
abolished the behavioral activation and EEG desynchroniza-
tion induced by amphetamine (Florio et al., 1975; Marley 
and Nistico, 1975) and methamphetamine (Gogolak and Stumpf, 
1969); however, the EEG arousal produced by physostigmine 
was unaffected by clonidine (Gogolak and Stumpf, 1969). 
Clonidine also increased the threshold of the EEG-arousal 
reaction caused by reticular stimulation (Gogolak and Stumpf, 
19 69) . 
Behavioral and electrocortical sleep induced by intra-
ventricular administration of clonidine (5-15 ug) was easily 
interrupted by an arousing stimulus (Holman et al., 1971) 
and presentation of sensory stimuli during clonidine-induced 
sleep, induced behavioral and phasic electrocortical arousal 
(Marley and Nistico, 1975). 
In conclusion, several studies have demonstrated a 
sedative or sleep-inducing action of clonidine. These in-
vestigations suggest that the sleep-inducing effect of 
clonidine occurs through a stimulatory action of this drug 
at central alpha-noradrenergic receptors (Florio et al., 
1975; Marley and Nistico, 1975). It does not appear that the 
sleep-inducing action of clonidine depends on serotonergic 
transmission (Holman et al., 1971). 
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H. Analgesia 
Investigations of the neurochemical mechanisms underly-
ing the perception of painful stimuli suggest the involve-
ment of serotonin, and catecholamines and possibly other 
neurotransmitters (for review see Seiden and Dykstra, 1977). 
Furthermore, data suggests that serotonin and catecholamines 
are involved in the mediation of narcotic analgesia (for 
review see Seiden and Dykstra, 1977). 
The antinociceptive activity of clonidine has been 
demonstrated in a variety of procedures believed to induce 
pain in laboratory animals including electrical stimulation 
of the tail; Charpentier's test (Paalzow, 1974; Paalzow and 
Paalzow, 1976; Schmitt et al., 1974), placing the animal on 
a hot (560C) plate; hot-plate test (Schmitt et al., 1974), 
immersion of the tail in hot (55°c) water; tail withdrawal 
test (Sewell and Spencer, 1975; Fielding et al., 1977, in 
press), exposure of the tail to radiant heat; tail flick 
test (Fielding et al., 1977, 1978), applicationofpressure 
to an inflamed paw; Randall-Selitto test (Fielding et al., 
1977, in press) and intraperitoneal injection of phenyl-
p-benzoquinone (Fielding et al., 1977, in press), acetic 
acid or acetylcholine; writhing tests (Bentley et al., 1977). 
Furthermore, in all of the above procedures (except the tail 
withdrawal test in rats, Fielding et al., 1977, in press) 
clonidine was found to be more potent than morphine. 
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1. Charpentier's Test 
Paalzow (1974) measured the changes in the threshold 
for vocalization in mice and the threshold for motor re-
sponse (spinal reflex), vocalization and vocalization after 
discharge in mice and rats produced by electrical stimula-
tion of the tail. Subcutaneous administration of clonidine 
(0.08-1.25 mg/Kg) produced a dose-dependent increase (100-
500%) of the threshold for vocalization and vocalization 
after discharge in rats while the threshold for motor re-
sponse was unaffected (Paalzow, 1974). The threshold for 
a motor response was raised 100% at a dose of 10 mg/Kg, 
however, this dose produced sedation and marked sympatho-
metic signs (Paalzow, 1974). Clonidine also increased the 
threshold for vocalization in mice; however, the dose was 
higher (2.5-10.0 .1mg/Kg) than that required to produce a 
similar elevation in rats (Paalzow, 1974). 
Chlorpromazine (5 mg/Kg, s.c.), atropine (1 mg/Kg, 
s.c.) and p-chlorophenylalanine (400 mg/Kg, i.p.) pretreat-
ment increased the antinociceptive activity of clonidine 
(0.625 mg/Kg, s.c.) at both the threshold for vocalization 
and vocalization after discharge while phenoxybenzamine 
(10 mg/Kg, i.p.) and reserpine (10 mg/Kg, i.p.) pretreat-
ment increased the activity at the threshold for vocaliza-
tion only leaving the threshold for vocalization after 
discharge unaffected (Paalzow and Paalzow, 1976). Yohimbine 
(2 mg/Kg, i.p.) pretreatment decreased the antinociceptive 
activity of clonidine at both thresholds while 5-hydroxy-
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tryptophan (50 mg/Kg, i.p.) and alpha-methyl-para-p-tyrosine 
(250 mg/Kg, i.p.) pretreatment decreased the effects at the 
threshold for vocalization after discharge only (Paalzow 
and Paalzow, 1976). Naloxone (8 mg/Kg, s.c.) pretreatment 
or concomitant LSD (50 ug/Kg, s.c.) did not alter the anti-
nociceptive activity of clonidine at either pain response 
studied (Paalzow and Paalzow, 1976). 
Schmitt et al. (1974) reported the effect of clonidine 
on four types of behavioral reactions to the electrical 
stimulation of the rat's tail: startle, flight, vocaliza-
tion and biting of the electrodes. Intraperitoneal adrninis-
tration of clonidine (0.5-3 mg/Kg) produced a dose-dependent 
reduction on the startle, the cry and the biting of elec-
trodes; however, clonidine was weakly effective on flight 
(Schmitt et al., 1974). Intraventricular administration of 
clonidine (30 ug) reduced the startle and the biting of 
electrodes but was less effective on the startle and on the 
flight (Schmitt et al., 1974). Intraventricular adrninistra-
tion of clonidine was 5-7 times as potent as clonidine ad-
ministered intraperitoneally (Schmitt et al., 1974). 
2. Hot Plate Test 
The hot plate test measures the ability of drugs to 
inhibit reflex responses of mice placed on a hot place 
maintained at a constant temperature between 55° and 70° C 
(Seiden and Dykstra, 1977). A drug is said to produce 
analgesia when the reaction time to the heat is significantly 
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increased. Schmitt et al. (1974) reported that intraperi-
toneal (O.l and 1.0 mg/Kg) and intraventricular (.3-1 ug) 
administration of clonidine increased the reaction time to 
heat. The antinociceptive activity of clonidine in 
Charpentier's and the hot plate test appears to be medi-
ated centrally, since other alpha-sympathomimetics of the 
imidazoline series (naphazoline, tetryzoline and oxymetazo-
line) which do not cross the blood-brain barrier possess 
antinociceptive action only when administered intracerebro-
ventricularly (Schmitt et al., 1974). 
3. Tail Withdrawal Test 
The tail withdrawal test measures the ability of 
drugs to alter the amount of time required of mice or rats 
to withdraw their tail from hot water usually maintained at 
55°c. A drug is said to produce analgesia in this test if 
the time required for tail withdrawal is significantly in-
creased. 
Using the tail-withdrawal test in mice, Sewell and 
Spencer (1975) reported that subcutaneous administration of 
clonidine (0.3 mg/Kg) produced analgesia. However, when 
clonidine (0.5 mg) was injected intracerebroventricularly 
it possessed only marginal antinociceptive activity and 
furthermore substantially reduced the analgesic action of 
morphine (3 mg/Kg, s.c.) when given concurrently (Sewell 
and Spencer, 1975). The antinociceptive activity of sub-
cutaneously administered clonidine (0.3 mg/Kg) was signifi-
cantly antagonized by concurrent intraventricular 
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administration of phentolamine (5 mg) while the antinoci-
ceptive activity of subcutaneously administered morphine 
(3 mg/Kg) and pentazocine (15 mg/Kg) was significantly po-
tentiated by intraventricular injection of phentolamine 
(10 ug) (Sewell and Spencer, 1975). Intraventricular ad-
ministration of propranolol (10 ug) did not potentiate the 
antinociceptive activity of concurrent administration of 
subcutaneous doses of morphine (2.5 mg/Kg), pentazocine 
(15 mg/Kg) or clonidine (0.3 mg/Kg) (Sewell and Spencer, 
19 7 5) • 
Intraperitoneal administration of clonidine (2.5 and 
10.0 mg/Kg) in rats was effective in inhibiting tail-with-
drawal from hot water (Fielding et al., 1977, in press). 
Naloxone (5 mg/Kg) did not antagonize the antinociceptive 
action of clonidine (2.5 mg/Kg) (Fielding et al., 1977, 
in press). 
4. Tail Flick Test 
The tail flick test measures the ability of drugs 
to alter the time required of mice or rats to remove their 
tails from a radiant heat source. A drug is considered to 
produce analgesia in this test if the time required for 
removal of the tail from the heat is significantly increased. 
Subcutaneous administration of clonidine was reported 
to produce a dose-dependent (ED50 0.7 mg/Kg) inhibition of 
the tail flick response inmice (Fielding et al., 1977, 1978). 
The antinociceptive action of clonidine in this test was not 
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antagonized by naloxone (1.0 mg/Kg) (Fielding et al., 1977, 
1978) or phenoxybenzamine (10.0 mg/Kg) (Fielding et al., 
in press). 
Subcutaneous administration of clonidine (0.016 mg/Kg) 
potentiated the analgesic activity of :roo.rphine in the tail 
flick test approximately 5-fold while morphine (0.16 mg/Kg) 
potentiated the antinociceptive action of clonidine 4-fold 
(Spaulding et al., 1978). Naloxone reversed the enhanced 
effect of clonidine by morphine (Spaulding et al., 1978). 
Tolerance to the antinociceptive action of clonidine 
in the tail-withdrawal and tail flick procedures was not 
observed (Fielding et al., 1977). Furthermore, cross-toler-
ance to the antinociceptive action of clonidine in morphine-
pelleted mice was not observed (Spaulding et al., 1978). 
5. Randall-Selitto Test 
The Randall-Selitto test measures the ability of 
drugs to alter the reaction to pressure applied to an in-
f;Lamed paw by an "analgesia . meter." A drug is considered 
to produce analgesia in this procedure when the amount of 
pressure required to induce a reaction is significantly in-
creased. 
In a modified version of the Randall-Selitto test, 
Fielding et al. (1977, in press) reported that subcutaneous 
administration of clonidine (0.125-1.0 mg/Kg) produced a 
dose-dependent increase in the threshold to pain produced 
by pressure on an inflamed paw. 
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6. Writhing Tests 
Writhing tests measure the ability of drugs to al-
ter writhing induced by other chemical agents. A drug is 
considered to produce analgesia in this test when the number 
of writhes induced by the chemical agent is significantly 
decreased. 
Subcutaneous administration of clonidine (0.0125-0.05 
mg/Kg) into mice produced a dose-dependent inhibition of 
writhing induced by phenyl-p-benzoquinone (Fielding et al., 
1977, in press). The anti-writhing action of clonidine was 
not antagonized by naloxone (1.0 mg/Kg) (Fielding et al., 
1977, in press) or phenoxybenzamine (Fielding et al., 1977). 
Clonidine, oxymetazoline and 1-noradrenaline bitartar-
ate were equi-effective in antagonizing the nociceptive ac-
tion of acetic acid or acetylcholine when administered sub-
cutaneously in mice while phenylephrine was ineffective 
(Bentley et al., 1977). Clonidine was the most potent 
antagonist (Bentley et al., 1977). Piperoxane (8 and 16 
mg/Kg) antagonized the antinociceptive action of oxymetazo-
line and noradrenaline and partially antagonized the anti-
nociceptive effect of clonidine while phentolamine (16 mg/Kg) 
had no antagonistic effect on any of the three drugs 
(Bentley et al., 1977). Clonidine and oxymetazoline were 
more potent when administered intracisternally; however, 
their antinociceptive action when administered by this route 
was not antagonized by piperoxane (16 mg/Kg) administered 
subcutaneously or (50 ug/Kg) intracisternally (Bentley et 
al., 1977). 
In sununary, these investigations demonstrate that clo-
nidine produces a dose-dependent analgesia as measured by a 
variety of procedures considered to induce pain in laboratory 
animals. Clonidine-induced analgesia does not seem to be 
the result of an impairment of motor function since the 
threshold for a motor response (Paalzow, 1974) or flight 
reaction (Schmitt et al., 1974) is unaffected at doses which 
produce analgesia. The analgesic action of clonidine ap-
pears to be mediated centrally since other alpha-sympatho-
mimetics of the imidazoline series which do not cross the 
blood-brain barrier possess antinociceptive activity only 
when administered intracerebroventricularly (Schmitt et al., 
1974). However, the antinociceptive action of clonidine in 
writhing tests may be due to its stimulatory action on 
alpha-adrenoceptors located on sensory nerve endings in the 
peritoneum since other peripherally acting alpha-agonists 
are also antinocicpetive in these tests (Bentley et al., 
1977). Depending on the dose, route of administration and 
species, it appears that clonidine may increase (Spaulding 
et al., 1978) or decrease (Sewell and Spencer, 1975) the 
analgesic action of morphine. However, unlike narcotics 
tolerance to the antinociceptive action of clonidine is 
not observed (Fielding et al., 1977) nor is cross-tolerance 
observed in morphine-dependent mice (Spaulding et al., 
1978). The lack of naloxone antagonism of the antinocicep-
tive action of clonidine (Paalzow and Paalzow, 1976; 
Fielding et al., 1977, 1978) suggests that the analgesic 
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action of clonidine is not mediated through an interaction 
with opiate receptors. Based on the results of studies in-
vestigating the effect of other drugs on clonidine-induced 
analgesia (Paalzow and Paalzow, 1976; Sewell and Spencer, 
1975; Fielding et al., 1977, 1978; Bentley et al., 1977) 
it appears that several neurochemical systems may mediate 
the antinociceptive action of clonidine. 
I. Antiwithdrawal 
Recently, Redmond et al. (1976) and Redmond (1977) re-
ported that the effects of electrical or pharmacological 
activation of the locus coeruleus in monkeys were striking-
ly similar to those noted during opiate withdrawal. Thus 
it was suggested that the symptoms of opiate withdrawal were 
the result of excess noradrenergic activity within the locus 
coeruleus (Redmond, 1977). 
Fielding et al. (1977; in press) reported that cloni-
dine (0.01-0.16 mg/Kg) decreased morphine withdrawal wet 
shakes when intraperitoneally administered to morphine-
dependent rats during withdrawal produced by discontinuation 
of morphine administration. Similarly, Tseng et al. (1975) 
and Vetulani and Bednarczyk (1977) reported that clonidine 
(0.1-0.8 mg/Kg) decreased wet shakes produced by administra-
tion of narcotic antagonists in morphine-dependent rats. 
Furthermore, clonidine (5 ug/Kg) has been reported to elimi-
nate opiate withdrawal signs in narcotic addicts undergoing 
voluntary detoxification (Gold et al., 1978; Washton, et 
al., 1978). 
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The ability of clonidine to decrease narcotic withdraw-
al does not seem to be mediated through a drug action at 
opiate receptors. Naloxone did not antagonize the ability 
of clonidine to decrease wet shakes in rats (Fielding et al., 
in press) nor did naloxone precipitate withdrawal in a 
clonidine-maintained opiate-free individual or block the 
decrease in opiate withdrawal symptoms in humans (Washton 
et al., 1978). Because opiate withdrawal symptoms have been 
suggested to be the result of excessive noradrenergic ac-
tivity within the locus coeruleus (Redmond, 1977), the abil-
ity of clonidine to reduce opiate withdrawal symptoms may 
be the result of its stimulatory action at presynaptic alpha-
noradrenergic receptors of the locus coeruleus thus decreas-
ing noradrenergic activity. This suggestion is supported 
by the finding that the opiate withdrawal-like symptoms 
produced by electrical or pharmacological activation of the 
locus coeruleus are blocked by clonidine (Redmond, 1977). 
Clonidine has also been reported to decrease the 
sweating, tremor and anxiety associated with alcohol with-
drawal in humans (Bjorkqvist, 1975). 
In conclusion, studies of the effect of clonidine in 
the treatment of narcotic and alcohol withdrawal suggest 
that clonidine may provide a non-opiate treatment for nar-
cotic withdrawal (Washton et al., 1978) and may be useful 
in the treatment of other drug withdrawal states associ-
ated with anxiety and increased noradrenergic activity. 
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J. Food and Water Consumption 
Investigations of the neurochemical mechanisms under-
lying feeding and drinking behavior suggest that alpha-
noradrenergic mechanisms may elicit these behaviors (for 
review see Seiden and Dykstra, 1977). In dogs, clonidine 
increased food intake at low doses and reduced it at high 
doses (Le Douarec et al., 1972). In rats clonidine re-
duced food intake (Le Douarec et al., 1972). Piperoxane 
antagonized the inhibitory effect of clonidine on food in-
take in rats while yohimbine and phentolamine provided 
partial antagonism. However, many alpha-adrenergic recep-
tor blockers such as tolazoline, dibenamine and phenoxy-
benzamine were ineffective as were beta-adrenergic receptor 
blockers (Le Douarec et al., 1972). 
Intrahypothalamic injection of clonidine increased 
food intake in satiated rats (Le Douarec et al., 1972). 
Similarly, Holman et al. (1971) reported that following in-
traventricular administration of clonidine (25-75 ug/Kg) 
in rats approximately one-third of the rats began eating 
continuously and sometimes periods of eating alternated 
with periods of sleep. 
In an investigation of the effect of clonidine on be-
havior associated with food intake, Poignant and Rismondo 
(1975) reported that clonidine (0.05-0.2 mg/Kg) increased 
the take-up time of a standard alimentary material in ham-
sters without affecting the associted hoarding behavior. 
In contrast, amphetamine (1 and 2 mg/Kg) modified both 
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take-up time and hoarding behavior (Poignant and Rismondo, 
19 7 5) . 
Clonidine reduced water intake and induced diuresis 
in rats given the opportunity to drink water after 18 hours 
of water deprivation (Le Douarec et al., 1971). The reduc-
tion in water intake was antagonized by piperoxane, tolazo-
line and phentolamine; however, other alpha-adrenergic re-
ceptor blockers such as dibenamine and phenoxybenzamine were 
ineffective (Le Douarec et al., 1971). Beta-adrenergic 
blockers as well as the cholinergic drugs atropine and mecam-
yline were devoid of any antagonistic activity (Le Douarec 
et al., 1971). 
In conclusion, clonidine may increase or decrease food 
intake depending on the dose, species, route of administra-
tion and food deprivation state of the animal (Le Douarec 
et al., 1972). However, clonidine's effect on water intake 
seems to be solely inhibitory (Le Douarec et al., 1971). 
Feeding elicited by intrahypothalamic (especially the peri-
fornical area) injection of norepinephrine in sated rats 
is blocked by the administration of alpha-noradrenergic 
receptor blockers (for review see Seiden and Dykstra, 1977), 
therefore clonidine's action to increase food intake in 
satiated rats may be the result of its stimulatory action 
at post-synaptic, alpha-receptors. However, because of 
the differential antagonism of the clonidine-induced decrease 
in food and water intake by alpha-adrenergic blocking 
agents, it appears that the receptors involved in mediating 
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these inhibitory effects ofclonidine have some properties 
in common with classical alpha-adrenergic receptors but 
are different in some way (Le Douarec et al., 1971, 1972). 
Since intrahypothalamic administration of norepine-
phrine in sated monkeys is reported to elicit drinking 
(Myers, 1969), the clonidine-induced decrease in the water 
intake of water deprived rats may be related to a stimula-
tory action of clonidine at pre-synaptic alpha-adrenergic 
receptors, thus decreasing noradrenergic transmission. 
However, it may be that clonidine's action on water intake 
depends on the water deprivation state (i.e. sated or de-
prived) of the subject. 
K. Body Temperature 
Thermoregulation normally involves the integration of 
both behavioral and physiological mechanisms. Investiga-
tions of the role of central neurotransmitters in thermoregu-
lation suggests the involvement of both catecholamines and 
serotonin (Stricker and Zigmond, 1976; Cooper et al., 1978). 
Wendt and Caspers (1968) reported a suppression of 
sweating in man during heat exposure and exercise after 
oral administration of 75 and 150 ug (about 1 and 2 ug/Kg) 
clonidine, while Laverty and Taylor (1969) observed a fall 
in body temperature when clonidine (0.1-2.5 mg/Kg) was ad-
ministered subcutaneously into rats. Similarly, Tsoucaris-
Kupfer and Schmitt (1972) found that subcutaneous or intra-
peritoneal administration of clonidine (0.5-1.5 mg/Kg) 
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induced hypothermia in rats, the intensity and duration of 
which was dose-dependent. Intraventricular injection of 
clonidine (15 ug) (Tseng et al., 1975), but not (2-3 ug) 
(Tsoucaris-Kupfer and Schmitt, 1972) lowered body tempera-
ture in rats and produced a dose-dependent (0.02-0.2 urnol) 
hypothermia in young chicks (Marley and Nistico, 1975). 
Intrahypothalamic administration of clonidine (3 ug or 
0.04 urnol) is also reported to produce hypothermia 
(Tsoucaris-Kupfer and Schmitt, 1972; Marley and Nistico, 
1975). 
The hypothermia produced by the various routes of clo-
nidine administration was antagonized by the alpha-blocking 
agents phentolamine, phenoxybenzarnine, piperoxane, tolazo-
line and dibenarnine (Tsoucaris-Kupfer and Schmitt, 1972; 
Reid et al., 1975; Marley and Nistico, 1975). Piperoxane 
was the most effective antagonist (Tsoucaris-Kupfer and 
Schmitt, 1972). The beta-adrenergic receptor antagonists, 
propranolol, pindolol and Ko 1366 were also reported to be 
effective in decreasing the hypothermic effect of clonidine 
(Tsoucaris-Kupfer and Schmitt, 1972). However, Reid et 
al. (1975) and Marley and Nistico (1975) reported that pro-
pranolol did not alter the hypotherrnic action of clonidine. 
Similarly, Tsoucaris-Kupfer and Schmitt (19722), reported 
that atropine and haloperidol were effective in decreasing 
the hypotherrnic effect of clonidine while mecamyline and 
imipramine were ineffective. However, Maj et al.. ( 19 7 5) 
and Marley and Nistico (1975) reported that atropine did 
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not affect clonidine-induced hypothermia and Reid et al. 
(1975) reported that the relatively selective dopamine re-
ceptors antagonist did not alter the hypothermic effect of 
clonidine. Furthermore, Marley and Nistico (1975) reported 
that haloperidol did not attenuate the hypothermic effect 
of clonidine. Other alpha-sympathomimetic imidazolines 
such as naphazoline, tetryzoline and oxymetazoline, which 
do not cross the blood-brain barrier (Walland, 1977); were 
also effective in producing hypothermia after peripheral 
~dministration (Tsoucaris-Kupfer and Schmitt, 1972). Fur-
thermore, depletion of brain catecholamines by intracister-
nal administration of 6-0HDA failed to alter the hypothermic 
I 
response to clonidine (Reid et al., 1975). Therefore, the 
hypothermic effect of clonidine may be due to an action at 
both central and peripheral sites. 
Scheel-Kruger and Hasselager (1974) reported that the 
hypothermia induced by clonidine (0.5 mg/Kg) in rats could 
be antagonized by apomorphine (2 x 2.5 mg/Kg). It was sug-
gested that the hypothermic effect of clonidine was due to 
its action on serotonin turnover since apomorphine also 
produced a significant antagonism of the clonidine-induced 
decrease of 5-hydroxy-indole acetic acid levels, the time 
course of which correlated with its antagonism of clonidine-
induced hypothermia (Scheel-Kruger and Hasselager, 1974). 
However, Marley and Nistico (1975) reported that intraven-
tricular pretreatment with the serotonin receptor blocker, 
methysergide (0.1 umol) did not attenuate the hypothermic 
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effect produced by intraventricular injection of clonidine 
(0.05-0.2 umol). 
Finally, Tseng et al. (1975) reported that intraperi-
toneal (0.1-0.4 mg/Kg) or intraventricular (5 and 15 ug) 
administration of clonidine inhibited precipitated shakes 
and potentiated escape attempts induced by naloxone in 
morphine-dependent rats. These forms of morphine-withdrawal 
were previously suggested (Wei et al., 1974) to be related 
to heat gain and heat loss mechanisms, respectively. 
In conclusion, these findings demonstrate that cloni-
dine produces hypothermia via several routes of administra-
tion. Because of the antagonism of clonidine-induced hypo-
thermia by alpha-adrenergic blocking agents it appears that 
the hypothermic action of clonidine is mediated by its 
stimulatory action at alpha-adrenergic receptors. This is 
supported by the finding that hypothermia induced by intra-
ventricular administration of norepinephrine is antagonized 
by phentolamine (Burks, 1972). However, as suggested by 
Scheel-Kruger and Hasselager (1974) the hypothermic effect 
of clonidine may be secondary to its action on noradrener-
gic receptors and may be the result of the clonidine-induced 
decrease in serotonin turnover (Anden et al., 1970; Scheel-
Kruger and Hasselager, 1974; Rochette and Bralet, 1975). 
Feldberg (1964) reported that intraventricular administra-
tion of serotonin produces hyperthermia, therefore it would 
follow that a reduction in serotonin turnover produced by 
clonidine would produce hypothermia. Finally, it cannot be 
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stated with certainty whether or not the hypothermic action 
of clonidine occurs at central or peripheral alpha-adrener-
gic receptors or both, since other imidazoline sympatho-
mimetics which do not cross the blood-brain barrier also 
produce hypothermia when administered peripherally. 
L. Conclusion 
In addition to its action on the noradrenergic system 
clonidine has also been reported to affect other central 
neurotransmitter systems. Similarly, in addition to its 
antihypertensive action, clonidine is reported to produce 
several other pharmacological effects. 
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METHODS 
Subjects 
The subjects were drug-naive male hooded rats of the 
Long-Evans strain (Charles River Breeding Laboratories, 
Wilmington, Mass.) weighing between 300-400 grams at the 
beginning of the investigation. Throughout the experiment 
the subjects were given continuous access to food and water. 
The animals were surgically prepared with chronic intra-
venous (jugular) catheters according to the method of Smith 
and Davis (1975) with the following modifications: 1) sodi-
um pentobarbital was used as the anesthetic; 2) the cannula 
was constructed from PE 50 tubing; 3) nitrofurazone powder 
was not applied to muscle before suturing together. 
Surgical Procedure 
Subjects were anesthetized with sodium pentobarbital 
(50 mg/Kg) administered intraperitoneally. On the ventral 
surface the fur was shaved from the upper chest and lower 
neck and on the dorsal surface from the back of the neck 
just behind the ears. Gauze soaked in a 95% ethanol solu-
tion was used to cleanse these areas. With the animals in 
a supine position a skin incision (approximately 2 cm in 
length), which extended from the upper chest toward the 
lower neck was made with a scalpel on the right side of 
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the animal above the jugular vein. Utilizing blunt dis-
section technique the underlying chest muscles were sepa-
rated until the right jugular vein was exposed. The vein 
was then isolated (using needlepoint tweezers) by care-
fully removing the fat and connective tissue surrounding 
it. A trocar was placed under the vein to keep it isolated. 
sterile surgical silk (Ethicon 000 Silk; Ethicon Inc., 
Somerville, N.J.) was tied in a loose knot around the vein 
as far caudad as possible. Using needlenose scissors, an 
incision was made halfway through the vein. A catheter 
(polyethylene 50 (PESO)) tubing; (Clay Adams, Parsipanny, 
N.J.) filled with physiological saline was inserted into 
the lumen of vein for 1/2" of its length. The silk was im-
mediately tied tightly around the vein and cannula. Silk 
was tied a second time around the vein and cannula just 
cephalad to the first tie. Saline (approximately .2 ml) 
was administered through the catheter into the vein to 
compensate for any blood loss and to check for leaks. 
The cannula was considered to be in the vein when blood 
could be withdrawn as the plunger was pulled back. Using 
hollow metal tubing, pointed at one end, the catheter was 
passed subcutaneously under the right forelimb and out 
through the shaved area on the dorsal surface of the neck. 
The catheter was further secured by tying it (with Ethicon 
000 Silk) to underlying muscle at two other points, thus 
forming a triangle with the first ties. Sterile surgical 
gut (Ethicon 5-0 Chromic) was used to suture the overlying 
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muscle together. Finally, sterile srugical silk was used 
to close the skin incision. CombioticR (60,000 units; 
Pfizer, New York, N.Y.) was injected intramuscularly into 
a hind leg to give protection against possible infection. 
Animals were subsequently placed in velcro harnesses so 
that a saddle was strapped behind their forelegs. The 
catheter was passed through the harness and through a pro-
tective metal coil attached to the harness. Subjects were 
allowed 24 hours to recover from this surgical procedure 
before being placed in the self-administration apparatus. 
Apparatus 
The self-administration apparatus consisted of conven-
tional plexiglass operant chambers 26 x 20 cm and 26 cm 
high enclosed in lightproof, ventilated, sound-attenuating 
chambers. The outer chambers contained a houselight turned 
on between 8:00 A.M. and 8:00 P.M. A response lever 4 cm 
wide extended 3 cm into the operant chambers 3.5 cm above 
the floor in the center of the short wall. As the catheter 
emerged from the protective metal coil it passed through 
the roof of the operant chamber and through the roof of the 
outer chamber to where it was eventually connected to a 
pneumatic driven Hamilton Precision Liquid Dispenser (PLD) 
syringe (Hamilton Co., Reno, Nevada) located on top of the 
outer chamber. Depression of the response lever (weight 
required 15 grams) activated the PLD syringe to deliver a 
constant volume (100 ul/Kg) of a drug solution in less 
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than one second into the jugular vein of the subject via 
the catheter. All programming and response recording was 
performed utilizing electromechanical equipment (Lehigh 
Valley Electronics, Lehigh Valley, Pa.). Each day at the 
same time the number of lever presses was recorded. 
Drugs 
Clonidine hydrochloride (Boehringer Ingelheim Ltd., 
Ridgefield, Ct.), fentanyl citrate (McNeil Laboratories, 
Inc., Fort Washington, Pa.), and naloxone hydrochloride 
(Endo Laboratories, Inc., Garden City, N.Y.) were dis-
solved in 0.9% sodium chloride. Haloperidol, azaperone 
and aceperone (Janssen Pharmaceutica N.V., Beerse, Belgium) 
were dissolved in 0.3% tartaric acid. 
Experimental Design 
A total of 90 rats were used in this investigation. 
Three rats were allowed to self-administer fentanyl (0.1 
ug/Kg/injection) while 46 rats were allowed to self-ad-
minister fentanyl at a dose of 1 ug/Kg/injection. Thirty-
eigh t rats were allowed to self-administer clonidine 
(15 ug/Kg/injection) whereas three rats were allowed to 
self-administer saline. All solutions were self-adminis-
tered on a continuous reinforcement (CRF) schedule. 
61 
A. Fentanyl Self-Administration 
1. Effect of Increasing the Fentanyl Dose Per Injection 
When, after four days of self-administration, lever 
pressing rates of three rats allowed to self-administer 
fentanyl (0.1 ug/Kg/injection) did not differ from lever 
pressing rates of rats allowed to self-administer saline, 
the fentanyl dose was increased to 1 ug/Kg/injection. The 
effect of increasing the fentanyl dose on self-administration 
behavior was measured by comparing the response rates at 
each dose of fentanyl. 
2. Effect of Clonidine and Saline Substitution for the 
Fentanyl Solution 
Twenty-one of the 46 rats allowed to self-administer 
fentanyl (1 ug/Kg/injection) did not receive any other 
treatment. However, for four of the 46 rats allowed to self-
administer fentanyl (1 ug/Kg/injection), clonidine (15 ug/Kg/ 
injection) was substituted for the fentanyl solution when 
a stable rate of fentanyl-reinforced responding was achieved. 
A stable rate of fentanyl-reinforced responding was con-
sidered to have been achieved when the number of lever 
presses to obtain fentanyl injections for each rat on two 
consecutive days was within 20% of the mean number of lever 
presses for those two days. Similarly, for two out of the 
46 rats, clonidine (1 ug/Kg/injection) was substituted for 
fentanyl and for three out of the 46 rats saline was substi-
tuted. Following substitution, subjects were allowed to 
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self-administer clonidine or saline for four consecutive 
days. The effect of substituting clonidine and saline for 
the fentanyl solution was measured by comparing the rate 
of self-administration following clonidine and saline sub-
stitution to the rate of fentanyl self-administration be-
fore substitution. 
3. Effect of Adding Various Drugs to the Fentanyl Solu-
tion for Self-Administration of the Drug Mixture 
For the remaining 16 of the 46 rats allowed to self-
administer (1 ug/Kg/injection), three different butyro-
phenones and naloxone were added to the fentanyl solution 
when a stable rate of fentanyl-reinforced responding was 
achieved. A stable rate of fentanyl-reinforced responding 
was considered to have been achieved when the number of 
lever presses to obtain fentanyl injections for each rat 
on two consecutive days was within 10% of the mean number 
of lever presses for those two days. Naloxone (N=3), 
haloperidol (N=4), aceperone (N=S) or azaperone (N=4) were 
added to the fentanyl solution for self-administration of 
the drug mixture so that the subjects received 64 ug/Kg/ 
injection. Each drug remained in the fentanyl solution 
for two or three consecutive days. Thereafter, the drugs 
were removed from the fentanyl solution and the subjects 
were allowed to self-administer fentanyl alone. The effect 
of the response contingent drug injections on fentanyl-
reinforced responding was measured by comparing the number 
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of lever presses to obtain the drug mixture with the number 
of lever presses for fentanyl alone before adding the drugs 
to the fentanyl solution. The number of lever presses for 
the drug mixture were expressed as a percentage of the mean 
number of lever presses for f entanyl alone for the two days 
before adding the drugs. The effect of the response-contin-
gent drug injections on fentanyl-reinf.orced responding was 
considered significant if, utilizing Scheffe's Test, p LO.OS. 
B. Clonidine Self-Administration 
1. Effect of Increasing the Fixed-Ratio Requirement 
Twenty-two out of 38 rats allowed to self-administer 
clonidine (15 ug/Kg/injection) did not receive any other 
treatment. However, in one rat allowed to self-administer 
clonidine on a CRF schedule the response requirement to ob-
tain each clonidine injection was progressively increased 
to a FR-3 and then to a FR-10 schedule of clonidine rein-
forcement. The response requirement was increased when the 
number of lever presses to obtain clonidine injections on 
the CRF schedule was within 10% of the mean for those three 
days. The subject was allowed to self-administer clonidine 
at each FR schedule for three consecutive days. The effect 
of increasing the response requirement on clonidine-rein-
forced responding was measured by comparing the number of 
lever presses to obtain clonidine-injections at each FR-
requirement and also by comparing the total amount of cloni-
dine intake at each FR requirement. Assuming independence 
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of the data the effect of increasing the FR requirement on 
the above measures was considered significant if, utilizing 
Tukey' s Test, p = c:: 0. 05. 
2. Effect of Adding Various Drugs to the Clonidine Solu-
tion for Self-Administration of the Drug Mixture 
For the remaining 15 of the 38 rats allowed to self-
administer clonidine (15 ug/Kg/injection), naloxone or three 
different butyrophenones were added to the clonidine solution 
when a stable rate of clonidine-reinforced responding was 
achieved. A stable rate of clonidine-reinforced responding 
was considered to have been achieved when the number of lever 
presses to obtain clonidine injections for each rat on two 
consecutive days was within 10% of the mean number of lever 
presses for those two days. Naloxone (N=3), haloperidol 
(N=7) , aceperone (N=3) or azaperone (N=3) were added to the 
clonidine solution so that the subjects received 64 ug/Kg/ 
injection. Each drug remained mixed with the clonidine solu-
tion for self-administration of the drug mixture for three 
consecutive days. Thereafter, the drugs were removed from 
the clonidine solution and subjects were allowed to self-
administer clonidine (15 ug/Kg/injection) alone. The effect 
of the response-contingent drug injections on clonidine-rein-
forced responding was measured as described for the effect 
of these drugs on fentanyl-reinforced responding. Similarly, 
the effect of the respone contingent drug injections was 
considered significant if, utilizing Scheffe's Test, p =<0.05. 
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RESULTS 
Acquisition of Fentanyl Self-Administration 
As shown in Figure 1, subjects readily began to self-
administer fentanyl (1 ug/Kg/injection) when an intravenous 
injection of this drug was made contingent on lever press-
ing on a continuous reinforcement (CRF) schedule. From 
day 1 to day 5 there was a gradual increase (m=74.5) in 
lever pressing to obtain fentanyl injections, thereafter 
the rate of self-administration stabilized. It is also 
shown that rats do not self-administer a lower dose (0.1 
ug/Kg/injection) of fentanyl nor saline when their intra-
venous delivery is made contingent on a CRF schedule. Self-
administration rates of the latter (Figure 1) reflect lever 
pressing produced by random locomotor activity. 
In rats previously allowed to self-administer fentanyl 
(0.1 ug/Kg/injection) on a CRF schedule, the substitution 
of a higher dose (1 ug/Kg/injection) of fentanyl to be de-
livered on a CRF schedule promoted self-administration be-
havior (Figure 2). On the fourth day of substitution (day 
8) self-administration rates similar to those on day 4 of 
drug-naive animals (Figure 1) were observed [252 + 73(3) vs. 
239 + 49 (21)]. 
Acquisition of Clonidine Self-Administration 
As shown in Figure 3, subjects readily began to self-
administer clonidine (15 ug/Kg/injection) when an intravenous 
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Figure 1. Acquisition of fentanyl self-administration 
in drug-naive rats when fentanyl (1 ug/Kg/injection) 
was delivered on a continuous reinforcement (CRF) 
schedule. Lack of acquisition of self-administration 
when 0.1 ug/Kg/inj fentanyl or saline (N=3) was de-
livered on a CRF schedule. Each value represents the 
mean + S.E. number of lever presses for the number 
of subjects indicated in parantheses. 
67 
I 
0 
(.JI 
0 
LEVER PRESSING I DAY 
MEAN + S.E. 
0 
0 
(JI 
0 
I\) 
0 
0 
I\) 
(.JI 
0 
(.>l 
0 
0 
(.>l 
(.JI 
0 
o_...~~~...i...~~~...i...~~~...i....~~~...i...~~~...i...~~~...i...~~~• 
' 
' 
' 
(JI 
' 
' 
' ' 
... 
I 
' ~ 0 
II JI 
0 2 
~ t 
cO cO 
....... ....... 
':/fl(" ';IC' 
tQ Cl 
....... ....... 
z z 
c.. C-
Figure 2. Acquisition of self-administration behavior 
upon substitution of a 1 ug/Kg/inj fentanyl solution to 
be delivered on a CRF schedule for a 0.1 ug/Kg/inj 
fentanyl solution delivered on a CRF schedule. Each 
value represents the mean + S.E. for three animals. 
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Figure 3. Acquisition of clonidine self-administration 
in drug-naive rats when clonidine (15 ug/Kg/inj) was 
made delivered on a CRF schedule. Lack of acquisition 
of self-administration when saline (N=3) control was 
delivered on a CRF schedule. Each value represents 
the mean + S.E. number of lever presses for the number 
of subjects indicated in parentheses. 
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injection of this drug was made contingent on lever pressing. 
An increase (m=49.9) in lever pressing to obtain clonidine 
injections was observed from day 1 to day 3, thereafter self-
administration rates stabilized. Five out of the 23 sub-
jects that began to self-administer clonidine died. The 
mean number of lever presses for lethality of these subjects 
was 108 + 12. 
Effect of Increasing the Fixed Ratio Requirement on Lever 
Pressing to Obtain Clonidine Injections 
When the fixed ratio (FR) requirement to obtain each 
clonidine injection was increased from FR-1 to FR-3 a small 
but significant (p< .05; Tukey Test) increase in lever 
pressing to obtain clonidine injections was observed (Figure 
4). However, total daily clonidine intake (Table 1) at 
the FR-3 schedule was decreased significantly (p< .05; Tukey 
Test) from the FR-1 schedule. On the other hand, when the 
the FR requirement was increased from FR-3 to FR-10 a sig-
nificant increase (p'- .01, Tukey Test) in lever pressing 
(Figure 4) to obtain clonidine injections was observed such 
that total daily clonidine intake at the FR-3 and FR-10 
schedules of clonidine reinforcement remained approximately 
the same (N.S., Tukey Test) at both schedules (Table 1). 
Clonidine intake at the FR-3 and FR-10 schedules of rein-
forcement was significantly below (p<:_.05; Tukey Test) that 
observed at the FR-1 schedule of clonidine reinforcement. 
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Figure 4. Effect of increasing the fixed ratio (FR) requirement on the rate of 
clonidine self-administration in one rat. A significant increase in lever 
pressing to obtain each clonidine injection was observed when the FR requirement 
was increased from FR-1 to FR-3 (p ~ .05; Tukey Test) and from FR-3 to FR-10 
(p ~ .001; Tukey Test). Values a~e the mean + S.E. for 3 days at each FR require-
ment. 
Table 1. Effect of Increasing the Fixed Ratio (FR) 
Requirement on the Total Daily Clonidine 
Intake of One Rat. 
Fixed Ratio Requirement 
1 
3 
10 
Clonidine Intake/Day1 
(mg/Kg) 
1.28 + 0.17 
0.71 + 0.13 2 
0.60 + 0.012,3 
1
values are the mean + S.E. for 3 days at each FR re-
quirement. 
2significantly different (p < .05; Tukey Test) from 
clonidine intake at FR-1 requirement. 
3Not significantly different (p~.05; Tukey Test) from 
clonidine intake at FR-3 requirement. 
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Effect of Substituting Clonidine and Saline on Self-Ad-
ministration Rates in Rats Previously Self-Administering 
Fentanyl 
As shown in Figure 5, substitution of clonidine so that 
the subjects received 15 ug/Kg/injection maintained self-
administration behavior in rats previously self-administer-
ing fentanyl (1 ug/Kg/injection). However, the substitution 
of clonidine (1 ug/Kg/injection) or saline for the fentanyl 
solution resulted in extinction of the self-administration 
behavior. One rat died within eleven hours following sub-
stitution of clonidine (15 ug/Kg/injection). 
Effect of Adding Naloxone to the Clonidine and Fentanyl So-
lutions for Self-Administration of the Drug Mixture 
As shown in Table 2, addition of naloxone to the cloni-
dine and fentanyl solutions so that the subjects received 
64 ug/Kg/injection produced a significant decrease (p~ 0 .01; 
Scheffe's Test) in the self-administration rates of rats 
previously self-administering fentanyl but did not on day 1 
of addition, decrease the self-administration rates of 
rats previously self-administering clonidine (p/O .05). 
In rats previously self-administering fentanyl, rates of 
self-administration remained significantly below (p<0.01; 
Scheffe's Test) pre-naloxone rates while naloxone remained 
mixed with the fentanyl solution. Removal of naloxone 
(post-naloxone) from the fentanyl solution resulted in a 
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Figure 5. Effect of substituting clonidine and saline on 
rate of self-administration in rats previously self-
administering fentanyl (1 ug/Kg/inj) on a CRF schedule. 
The square at Day 1 is the mean + S.E. of the 3 days 
prior to substitution for all subjects. Substitution of 
clonidine (15 ug/Kg/inj) N=4; (1 ug/Kg/inj) N=2; saline 
N=3. Values are expressed as a percentage of the mean 
+ S.E. of Day 1. 
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Table 2. Effect of Adding Naloxone to the Clonidine and 
Fentanyl Solutions for Self-Administration of 
the Drug Mixture.l 
DAY % Clonidine Alone2 
Pre-
Naloxone 100 + 14 ( 3) 
-
Naloxone 1 114 + 14 ( 3) 
-
2 153 (2) 
3 
Post-
Naloxone 1 173 (2) 
2 
3 
% Fentanyl Alone 
100 + 2 ( 3) 
-
25 + 10 ( 3) 
-
6 + 2 ( 3) 
-
7 + 3 ( 3) 
34 + 13(3) 
88 + 28(3) 
126 + 25(3) 
2 
1Naloxone (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/ 
inj) and fentanyl (1 ug/Kg/inj) solutions for self-
administration of the drug mixture on a CRF schedule. 
2Pre-naloxone value was obtained by taking the mean + S.E. 
of the percentages of the mean number of lever presses of 
the two days prior to adding naloxone for each rat. Other 
values are mean + S.E. and are expressed as a percentage 
of the pre-naloxone rate for the number of rats indicated 
in parentheses. Only mean is presented where N was less 
than three. Decreasing N was the result of technical 
difficulties. 
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return towards pre-naloxone rates of self-administration. 
Data indicated that self-administration rates following re-
moval of naloxone (post-naloxone) from the fentanyl solu-
tion were not significantly different (P ~.05; Scheffe's 
Test) from self-administration rates before the addition 
of naloxone (pre-naloxone) to the fentanyl solution. How-
ever, post-naloxone self-administration rates were signif-
icantly higher (p <::::0.01, Scheffe's Test) than the rates 
of self-administration when naloxone was mixed with the 
fentanyl solution. 
In rats previously self-administering the clonidine-
naloxone mixture, removal of naloxone from the clonidine 
solution tended to result in an increase in self-adminis-
tra tion rates above pre-naloxone rates. Rates of self-
administration following the removal of naloxone did not 
appear to increase above self-administration rates of 
the clonidine-naloxone mixture, however, the number of 
subjects was too small to determine statistical signifi-
cance. 
Effect of Adding Haloperidol to the Clonidine and Fentanyl 
Solutions for Self-Administration of the Drug Mixture 
As presented in Table 3, the addition of haloperidol 
to the clonidine and fentanyl solutions so that the sub-
jects received 64 ug/Kg/injection resulted in a significant 
decrease (p tt::'- 0.01; Scheffe's Test) in the self-administra-
tion rates of rats previously self-administering either 
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Table 3. Effect of Adding Haloperidol to the Clonidine and 
Fentanyl Solutions for Self-Administration of the 
Drug Mixture.l 
DAY 
Pre-
Haloper idol 
Haloperidol 1 
2 
3 
Post-
Haloperidol 1 
2 
3 
4 
1 
% Clonidine Alone 
100 + 2 ( 7) 
-
17 + 3 ( 7) 
-
16 + 2 ( 5) 
-
17 + 2 ( 5) 
-
65 ( 2) 
70 (2) 
83 (2) 
9 5 (2) 
2 
% Fentanyl Alone 
100 + 8 ( 4) 
-
22 + 8 ( 4) 
-
27 + 6 ( 3) 
-
50 ( 2) 
103 (2) 
Haloperidol (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/ 
inj) and fentanyl ( ug/Kg/inj) solutions for self-administra-
tion of the drug mixture on a CRF schedule. 
2 
2 
Pre-haloperidol values were obtained by taking the mean + S.E. 
of the percentages of the mean of the two days prior to adding 
haloperidol for each rat. Other values are mean + S.E. and 
are expressed as percentage of the pre-haloperidol rate for 
the number of rats indicated in parentheses. Only mean is 
presented where N was less than three. Decreasing N was the 
result of technical difficulties. 
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clonidine or fentanyl alone. Depression of self-adminis-
tration rates was maintained below (p <::. 0.01; Scheffe's 
Test) pre-haloperidol rates while haloperidol remained in 
the clonidine and fentanyl solutions. Self-administration 
rates following the removal of haloperidol (post-haloperi-
dol) from the clonidine and fentanyl solutions tended to 
return to pre-haloperidol rates, however the number of 
subjects was too small to determine a statistical difference. 
Effect of Adding Aceperone to the Clonidine and Fentanyl 
Solutions for Self-Administration of the Drug Mixture 
Addition of aceperone to the clonidine solution so that 
the subjects received 64 ug/Kg/injection had no significant 
effect (p ::::> 0. 05 Scheffe' s Test) on rates of self-adminis-
tration in rats previously self-administering clonidine 
alone (Table 4). The rate of clonidine self-administration 
of one rat following the removal of aceperone from the 
clonidine solution was approximately the same as the pre-
aceperone response rate for this rat. Addition of aceper-
one to the fentanyl solution so that subjects received 
64 ug/Kg/injection resulted in a significant increase 
(pL.. 0.01; Scheffe's Test) in the rates of self-administra-
tion of rats previously self-administering fentanyl alone. 
The rates of self-administration remained significantly 
above (p<:::.0.01; Scheffe's Test) pre-aceperone rates while 
aceperone remained in the fentanyl solution. Removal of 
aceperone from the f entanyl solution tended to result in 
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Table 4. Effect of Adding Aceperone to the Clonidine and 
Fentanyl Solutions for Self-Administration of 
the Drug Mixture.l 
DAY % Clonidine Alone 2 
Pre-
Ace per one 99 + 5 ( 3) 
-
Aceperone 1 136 + 30 ( 3) 
-
2 146 + 5 ( 3) 
-
3 125 + 12 ( 3) 
-
Post-
Aceperone 1 83 (1) 
2 94 (1) 
3 88 (1) 
1 
2 % Fentanyl Alone 
100 + 3 ( 5) 
-
186 + 25(5) 
-
221 + 5 3 ( 4) 
-
238 + 51 ( 3) 
-
251 ( 2) 
320 (2) 
408 (2) 
Aceperone ( 64 ug/Kg/ inj) was added to clonidine (15 ug/Kg/ 
inj) and f entanyl ( 1 ug/Kg/inj) solutions for self-adminis-
tration of the drug mixture on a CRF schedule. 
2 
Pre-aceperone values were obtained by taking the mean + S.E. 
of the percentages of the mean of the two days prior to-add-
ing aceperone for each rat. Other values are mean + S.E. and 
are expressed as percentage of the pre-aceperone rate for the 
number of rats indicated in parentheses. Only mean is pre-
sented where N was less than three. Decreasing N was the 
result of technical difficulties. 
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an increase in rates of self-administration above rates of 
self-administration when aceperone was mixed with the 
fentanyl solution. However, the number of subjects was too 
small to determine a statistical significance. 
Effect of Adding Azaperone to the Clonidine and Fentanyl 
Solutions for Self-Administration of the Drug Mixture 
Addition of azaperone to the clonidine solution so 
that the subjects received 64 ug/Kg/injection tended to 
decrease the self-administration rates of rats previously 
self-administering fentanyl alone (Table 5). However, the 
number of subjects was too small to determine a statistical 
significance. Addition of azaperone to the fentanyl solu-
tion so that the subjects received 64 ug/Kg/injection re-
sulted in a significant decrease in the self-administration 
rates of rats previously self-administering fentanyl alone. 
The rates of self-administration remained below pre-azaper-
one rates while azaperone remained in the clonidine and 
fentanyl solutions. Removal of azaperone (post-azaperone) 
from the clonidine and fentanyl solutions tended to produce 
a return towards pre-azaperone rates of self-administration, 
however, the number of subjects was not large enough to de-
termine a statistical significance. 
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Table 5. Effect of Adding Azaperone to the Clonidine and 
Fentanyl Solutions for Self-Administration of the 
Drug Mixture. 
Pre-
Azaperone 
Azaperone 
Post-
Azaperone 
1 
DAY 
1 
2 
3 
1 
2 
3 
% Clonidine Alone 2 
100 + 19(2) 
2 6 (2) 
30 (2) 
34 ( 2) 
6 5 ( 1) 
9 3 ( 1) 
98 ( 1) 
% Fentany l Alone 2 
100 + 3 (4) 
35 + 8(4) 
44 + 8(4) 
22 ( 1) 
96 (2) 
Azaperone (64 ug/Kg/inj) was added to clonidine (15 ug/Kg/ 
inj) and fentanyl (1 ug/Kg/inj) solutions for self-administra-
tion of the drug mixture on a CRF schedule. 
2 
Pre-azaperone values were obtained by taking the mean + S.E. 
of the percentages of the mean of the two days prior to-add-
ing azaperone for each rat. Other values are mean + S.E. and 
are expressed as percentage of the pre-azaperone rate for the 
number of rats indicated in parentheses. Only mean is pre-
sented where N was less than three. Decreasing N was the 
result of technical difficulties. 
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DISCUSSION 
Acquisition of Fentanyl Self-Administration 
A number of narcotics (for review see Seiden and Dykstra, 
1977) are known to maintain behavior leading to their admin-
istration (i.e. to act as positive reinforcers). 
The rate and pattern of narcotic self-administration de-
pends on several factors including the narcotic, dose per 
injection, amount of time the drug is available, number of 
responses required to obtain the drug injection or schedule 
of reinforcement, experience of the subject and environmental 
conditions. 
Fentanyl is a synthetic narcotic which is approximately 
80 times more potent than morphine as an analgesic (Jaffe 
and Martin, 1975). When an intravenous injection of fentanyl 
(1 ug/Kg/injection) was made contingent on lever pressing, 
drug-naive rats readily began to lever press to obtain injec-
tions of this drug; that is, they began to self-administer it. 
Lever pressing to obtain fentanyl injections gradully in-
creased over the first five days from a mean of 44 + 12 
(N=21) lever presses on day one of self-administration to a 
mean of 350 + 114 (N=l7) by day five of self-administration. 
The mean number of lever presses to obtain fentanyl injec-
tions remained approximately the same from day five to day 
seven. Average daily fentanyl intake for these three days 
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was 358 ug/Kg/day. Therefore, it is demonstrated that fen-
tanyl (1 ug/Kg/injection) will function as a positive rein-
forcer as it will maintain behavior leading to its adminis-
tration. 
Under conditions of unlimited access, similar to those 
used in this investigation, Deneau et al. (1969) examined 
the pattern of morphine self-administration in rhesus monkeys. 
It was observed that morphine intake in these subjects in-
creased daily for 30 days after which it became stable. 
Therefore, the pattern of fentanyl self-administration re-
sembles the pattern of morphine self-administration in that 
there was a steady increase in self-administration rate and 
then a stabilization of self-administration rate for both 
narcotics. Since fentanyl is a much more rapidly acting 
and more potent narcotic than morphine this may explain the 
much faster acquisition and stabiliziation of fentanyl self-
administration. In addition, the dose per injection of each 
narcotic and the species difference certainly plays a role. 
When intravenous injection of a lower dose (0.1 ug/Kg/ 
injection) of fentanyl was made contingent on lever pressing 
subjects did not acquire self-administration behavior. Thus, 
suggesting that this dose of fentanyl does not possess rein-
forcing properties. That rates of self-administration for 
(0.1 ug/Kg/injection) fentanyl were not significantly differ-
ent from self-administration rates when saline was available 
supports this suggestion. 
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Self-administration behavior in rats previously allowed 
to self-administer fentanyl (0.1 ug/Kg/injection) was acquired 
however when the higher dose (1 ug/Kg/injection) of fentanyl 
was substituted. Rates of self-administration on day four 
of substitution were similar to rates of self-administration 
in rats not allowed to self-administer the lower dose initial-
ly. Thus a similar acquisition pattern for fentanyl (1 ug/ 
Kg/injection) was observed regardless of whether or not the 
subjects had previous experience in the operant chambers. 
While self-administering fentanyl (1 ug/Kg/injection) 
rats were alert and appeared healthy; occasionally, when the 
injection system failed (i.e. cannula became disconnected 
from the syringe) so that the subjects no longer received a 
fentanyl injection with each lever press, some rats exhibited 
narcotic withdrawal symptoms such as piloerection, diarrhea 
and ''wet shakes." The appearance and severity of these 
symptoms depended on how long the subject had been self-
administering fentanyl and also on the subject's rate of 
fentanyl self-administration. Therefore, self-administration 
of fentanyl (1 ug/Kg/injection) can produce physiological 
dependence as manifested by the appearance of a character-
istic abstinence syndrome upon termination of narcotic ad-
ministration. It is doubtful, however, if physiological de-
pendence is a necessary condition for fentanyl to function as 
a reinforcer as it has been previously reported that narcotics 
can function as reinforcers at doses too low to produce phy-
siological dependence (Schuster, 1968; Woods and Schuster 
1968, 1971; Hoffmeister and Schlichting, 1972). This is 
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demonstrated by higher response rates at these doses than 
when saline is available and also by the absence of withdraw-
al symptoms when the availability of narcotic injections is 
discontinued. 
Acquisition of Clonidine Self-Administration 
As discussed earlier the majority of evidence indicates 
that clonidine acts as an alpha-noradrenergic agonist in the 
central nervous system and depending on the dose administered 
may stimulate either pre- or post-synaptic noradrenergic re-
ceptors. Low doses (4-8 ug/Kg i.v.) have been reported to 
inhibit the firing of the noradrenergic neurons of the locus 
coeruleus (Svennson et al., 1975) and thus a pre-synaptic 
locus of action has been suggested, while higher doses (100 
ug/Kg i.p.) have been suggested to stimulate post-synaptic 
noradrenergic receptors (Anden et al., 1970). 
When an intravenous injection of clonidine (15 ug/Kg/ 
injection) was made contingent on lever pressing, drug-
naive rats readily began to lever press to obtain injections 
of the drug. The number of lever presses to obtain clonidine 
injections gradually increased over the first three days of 
self-administration from a mean of 69 + 22 (N=23) lever 
presses on day one to a mean of 169 + 32 (N=l3) lever presses 
by day three. The mean number of lever presses to obtain 
clonidine injections remained approximately the same from 
day 3 to day 5. Average daily clonidine intake for these 
three days was 2.8 mg/Kg. 
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The acquisition of clonidine self-administration was 
faster than the acquisition of fentanyl self-administration 
as demonstrated by a stable rate of clonidine-reinforced 
responding being achieved before a stable rate fentanyl-rein-
forced responding (3 days vs. 5 days). When daily intake 
of each drug did become stable, however, average daily 
clonidine intake was much higher than the average daily fen-
tanyl intake (2.81 mg/Kg vs. 0.358 mg/Kg). 
It cannot be stated with certainty whether or not the 
dose of clonidine self-administered by rats is stimulating 
pre- or post-synaptic noradrenergic receptors; however, be-
havioral and sympathomimetic signs exhibited by the rats sug-
gest that clonidine may be stimulating post-synaptic nora-
drenergic receptors. If clonidine were stimulating pre-
synaptic noradrenergic receptors this would inhibit norepine-
phrine release from noradrenergic nerve endings thus leading 
to reduced transmission in the noradrenergic system. It has 
been suggested that an action on pre-synaptic receptors could 
account for clonidine's depressant action on locomotor and/ 
or exploratory activity (Laverty and Taylor, 1969; Maj et al., 
1972; Strombom, 1976; Tilson, 1977). On the contrary, how-
ever, rats self-administering clonidine were highly excit-
able and made erratic movements when disturbed, leaping up 
into the roof of the operant chambers. If the door of the 
operant chamber were left open the subjects would try des-
perately to escape, thus demonstrating that locomotor and/or 
exploratory activity was not decreased. In fact, exploratory 
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may actually have increased as rats self-administering saline 
or fentanyl do not try to escape from the chamber when the 
door is left open. Clonidine has been reported to potentiate 
escape attempts induced by naloxone in morphine-dependent 
rats (Tseng et al., 1975), and to produce hyperactivity in 
mice following intraperitoneal administration of a large 
(5-30 mg/Kg) dose (Razzak, 1975). 
While self-administering clonidine the subjects exhibited 
marked sympathomimetic signs such as exopthalamus and pilo-
erection. These and other sympathomimetic signs such as, 
horripilation, tremor, and hyperactivity have been reported 
(Hoefke and Kobinger, 1966; Morpurgo, 1968; Razzak, 1975) 
when doses from 30-100 ug/Kg i.v. or 1-30 mg/Kg i.p. were ad-
ministered to mice. Furthermore, Morpurgo (1968) reported 
that administration of the alpha-noradrenergic receptor blocker 
phentolamine reversed the sympathomimetic signs. 
A liquid was noted to be secreted from the eyes of sub-
jects self-administering clonidine and eye pigmentation was 
observed to change ~rom a black color to an orange-brownish 
color. In cats and monkeys intravenous administration of 
clonidine (10 ug/Kg) was reported to reduce eye pressure in 
such a way that indicated marked vasoconstriction (Bill and 
Heilmann, 1975). Furthermore, Knapp and Galloway (1975) re-
ported that the eyes of a patient taking several drugs for 
hypertension, one of which was clonidine, began to turn a 
reddish color. However, a beta-blocker and not clonidine was 
thought to be responsible for this ocular reaction. 
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Constipation is a known side effect of clonidine and in-
deed subjects self-administering clonidine became severely 
constipated as evidenced by the absence of fecal matter on 
the wood shavings underneath the floor of the operant chamber. 
Dix and Johnson (1977) reported that rats chronically 
treated with clonidine maintained a poor coat condition. Sub-
jects self-administering clonidine also maintained a poor coat 
condition. Occasionally, when the injection system failed 
and the subject no longer received clonidine injections upon 
lever pressing, symptoms such as "wet shakes" and diarrhea 
were observed. Saperia (1975) reported that a man was troub-
led by diarrhea for four days following consumption of a large 
amount (5 mg) of clonidine. 
Clonidine has been reported to produce irritability and 
aggression in mice and rats (Morpurgo, 1968; Laverty and 
Taylor, 1969; Dix, 1977) and also to enhance morphine-with-
drawal and apomorphine-induced aggression in rats (Gianutsos 
et al., 1976). Rats self-administering clonidine assumed an 
attack posture and demonstrated aggressiveness towards the 
experimenter when a gloved hand was put into the operant 
chamber. Morpurgo (1968) reported that the clonidine-induced 
aggression was blocked by dopamine receptor antagonists such 
as haloperidol but poorly antagonized by norepinephrine re-
ceptor blockers and therefore concluded that the aggressive-
ness appears to be independent of clonidine's sympathomimetic 
effects. 
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When access to cocaine was unlimited, Deneau et al., 
(1969) reported that monkeys would self-administer the drug 
until convulsions and death occurred, usually within 30 days. 
Similarly , approximately 22% of subjects self-administering 
clonidine did so until death occurred, and this invariably 
occurred on day one of self-administration. Profuse saliva-
tion and complete loss of eye pigmentation was noted in these 
subjects. Several cases of clonidine overdose have been re-
ported in humans (Saperia, 1975; Wing et al., 1975; Hunyor 
et al., 1975; Moore and Philipi, 1976); however in none of 
these reports did overdose lead to death. Human overdose was 
always accompanied by severe hypertension and it was sug-
gested (Wing et al., 1975) that the clonidine overdose is a 
result of dominance of the peripheral alpha-agonist action 
of this drug (Rand and Wilson, 1968) over its central hypo-
tensive effects. Bradycardia was also noted in each case of 
human overdose and was treated by administration of atropine. 
Therefore, the cardiovascular effects of clonidine may be 
responsible for the death of subjects self-administering it. 
Since clonidine will maintain behavior leading to its 
administration in rats, it can be said to act as a positive 
reinforcer. Behavioral and sympathomimetic signs exhibited 
by rats self-administering clonidine suggest that the drug 
is stimulating post-synaptic noradrenergic receptors. 
Effect of Increasing the Fixed-Ratio Requirement on Clonidine 
Self-Administration Behavior 
In general experiments investigating the effect of 
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schedules of reinforcement on drug self-administration demon-
strate that drug reinf orcers generate response rates and pat-
terns characteristic of rates and patterns generated by other 
reinforcers such as food or water (McKearney and Morse, 1964; 
Thompson and Schuster, 1964; Woods and Schuster, 1968; Pickens 
and Thompson, 1971, 1972; Goldberg, 1973; Dougherty and 
Pickens, 1973; Balster and Schuster, 1973; Anderson and Thomp-
son, 1974; Downs and Woods, 1974; Iglauer and Woods, 1974; 
Goldberg et al., 1975; Goldberg and Kelleher, 1976; for re-
view (see Spealman and Goldberg, 1978), electric shock (Mc-
Kearney, 1968, 1969, 1970), or termination of a stimulus 
associated with occasional electric shocks (Kelleher and 
Morse, 1964; Morse and Kellheb , 1966). 
Intravenous administration of drugs of several pharma-
cological classes, including narcotic analgesics, narcotic 
antagonists, barbiturates and benzodiazepines dissociative 
anesthetics and psychomotor stimulants, has maintained re-
sponding by laboratory animals under fixed ratio: (FR) 
schedules of reinforcement (for review see Spealman and 
Goldberg, 1978). 
Delivery of an intravenous clonidine injection main-
tained responding in drug-naive rats when the drug was de-
livered on a FR-1 schedule of reinforcement. When the FR 
requirement to obtain each clonidine injection was increased 
from 1 to 3 responses per reinforcement, total daily clonidine 
intake decreased even though a significant increase in re-
sponding was observed. When the FR requirement was further 
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increased to FR-10, however, responding increased so that 
total daily clonidine intake at the FR-3 and FR-10 schedules 
of reinforcement were the sar.ie. 
Similar observations were made by Weeks (1962) who ex-
amined morphine intake under different FR schedules of rein-
forcement. When the FR requirement to obtain each morphine 
injection was increased from 1 to 5, morphine intake de-
creased even though responding to obtain the drug increased. 
However, when the FR requirement was increased to an FR-10, 
response rate doubled from its FR-5 level so that morphine 
intake remained the same at the FR-5 and FR-10 schedules of 
morphine reinforcement. 
Goldberg et al. (1971) increased the FR requirement for 
rhesus monkeys to obtain each intravenous pentobarbital in-
jection from 1 to 3 to 5 to 10 and observed a corresponding 
decrease in both response rate and total pentobarbital in-
take as the FR requirement was increased. Thus, even though 
both clonidine (Nickerson and Ruedy, 1975) and pentobarbital 
(Harvey, 1975) produce central nervous system depression, 
the effect of increasing the FR requirement on clonidine 
self-administration behavior does not resemble the effect of 
increasing the FR requirement on pentobarbital self-adminis-
tration behavior. These differential results may possibly 
suggest that the neurochemical mechanisms underlying the re-
inforcing properties of clonidine and pentobarbital are 
different. 
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When the psychomotor stimulants cocaine (Pickens, 1968; 
Pickens and Thompson, 1968; Goldberg et al., 1971) and amphet-
amine (Pickens and Harris, 1968) are delivered on FR schedules 
of reinforcement an increase in responding is observed as 
the FR requirement is increased so that total intake of these 
drugs remains constant. Therefore, in some respects the ef-
fect of increasing the FR requirement to obtain clonidine in-
jections resembles the effect of increasing the FR requirement 
to obtain psychomotor stimulants as increasing FR requirement 
to obtain each clonidine injection from 3 to 10 resulted in 
an increase in responding so that total clonidine intake re-
mained the same at these FR schedules of reinforcement. 
Effect of Substituting Clonidine and Saline on Self-Administra-
tion Behavior in Rats Previously Self-Administering Fentanyl 
It has recently been reported that clonidine and morphine 
have similar pharmacological effects on noradrenergic neurons 
(Gomes et al., 1976; Redmond, 1977). Of relevance to this 
discussion are the findings that both clonidine and morphine 
inhibit the firing of the noradrenergic nucleus locus coeruleus 
(Svensson et al., 1975; Korf, 1974) and that opiate receptors 
are located on locus coeruleus cell bodies (Kuhar et al., 
1974). 
Recently, Redmond et al. (1976) and Redmond (1977) re-
ported that the effects of electrical or pharmacological acti-
vation of locus coeruleus in monkeys were strikingly similar 
to those noted after opiate withdrawal in humans (anxiety 
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state) . Both clonidine and morphine blocked the effects of 
activation of the locus coeruleus (Redmond, 1977) and further-
more the time course correlated with the decreased neuronal 
activity in locus coeruleus (Svennson et al., 1975; Cedarbaum 
and Aghajanian, 1976; Cedarbaum and Aghajanian, 1977) and 
decreased norepinephrine release (Braestrup, 1974; Maas et 
al., 1976) produced by these drugs. Clonidine has been demon-
strated to decrease certain narcotic withdrawal signs, such 
as body shakes, induced by discontinuation of narcotic ad-
ministration (Fielding et al., 1977; in press) or by admin-
istration of narcotic antagonists (Tseng et al., 1975; 
Vetulani and Bednarczyk, 1977) in morphine-dependent rats. 
Gold et al. (1978) reported that clonidine eliminated opiate 
withdrawal signs in narcotic addicts and that all of the sub-
jects in the study reported dramatic relief of distress. In 
an earlier study Bjorkqvist (1975) reported that clonidine 
decreased the sweating, tremor and anxiety accompanying al-
cohol withdrawal in humans. 
Also of interest is the finding that clonidine produces 
analgesia in rats and mice (Paalzow, 1974; Paalzow and Paalzow, 
1976; Fielding et al., 1977; in press) and that the antinoci-
ceptive effects of clonidine are not reversed by naloxone 
(Paalzow and Paalzow, 1976; Fielding et al., in press) sug-
gesting that clonidine does not bind to opiate receptors. 
The above reports suggesting a similarity between cloni-
dine and narcotics are particularly interesting in view of 
the fact that self-administration behavior was maintained in 
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rats self-administering the narcotic fentanyl when clonidine 
(15 ug/Kg/injection) was substituted for the fentanyl solu-
tion. 
In general, all drugs that are abused by man are self-
administered by laboratory animals, while the reverse does 
not always hold true the similarities between clonidine and 
narcotics noted above and the abuse of narcotics by humans 
and their self-administration by laboratory animals suggest 
that clonidine may have abuse potential. There are no re-
ports of clonidine abuse among people, however, this could 
be due to its route of administration (orally) and also its 
prescription for hypertension. It is very interesting that 
patients in the Gold et al. (1978) study chose to be main-
tained on clonidine rather than methadone upon discharge 
from the hospital. While the authors do not report on the sub-
jective effects produced by clonidine in these opiate ad-
dicts, the subjective effects are of considerable importance. 
It could be that intravenous administration of clonidine by 
narcotic addicts produces the same subjective effects, 
''euphoria," as those produced by narcotics. However, cloni-
dine does not generalize to morphine in rats trained to dis-
criminate morphine from saline (Lal et al., 1977). There-
fore, clonidine may not produce the same subjective effects 
as narcotics since these effects are considered related to 
their discriminative stimulus properties (Lal and Gianutsos, 
1976; Lal et al., 1977), although in these discrimination 
studies both clonidine and morphine were administered 
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intraperitoneally. It cannot be stated with certainty there-
fore whether or not clonidine produces the same subjective 
effects as narcotics when administered intravenously. 
One subject died within eleven hours of the substitution 
of clonidine (15 ug/Kg/injection) for fentanyl. Complete 
loss of eye pigmentation (eyes white) was noted. In another 
rat the substitution of clonidine (15 ug/Kg/injection) led 
to self-mutilation of the forelimbs. Razzak (1975) reported 
that intraperitoneal administration of a large dose (50 mg/Kg) 
of clonidine produced self-mutilation in mice. 
Self-administration was not maintained in rats previous-
ly self-administering fentanyl; however, when a lower dose of 
clonidine (1 ug/Kg/injection) or saline was substituted for 
the fentanyl solution, Thompson and Pickens (1970) noted that 
when the opportunity to self-administer a narcotic or a psy-
chomotor stimulant was withdrawn, there was an initial in-
creas.e in responding followed by a gradual decrease. The 
increase in responding following the discontinuation of ad-
ministration of a positive reinforcer is referred to as an 
"extinction burst." This phenomenon was noted when clonidine 
(1 ug/Kg/injection) was substituted for fentanyl. On day 
one of substitution of clonidine (1 ug/Kg/injection) an in-
crease in responding above that observed for fentanyl alone 
was noted, thereafter responding gradually declined. 
Substitution of saline for the fentanyl solution also 
produced extinction of lever pressing behavior; however, no 
extinction burst was observed. This could be because lever 
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pressing was measured every 24 hours and therefore an initial 
increase in lever pressing during the early hours of substi-
tution was masked. Winger et al. (1975) reported that re-
sponding decreased less rapidly when saline was substituted 
for drug than when responding had no consequence. The some-
what different extinction patterns observed following the 
substitution of clonidine (1 ug/Kg/injection) and saline for 
the f entanyl solution could therefore be due to the mere 
presence and absence of drug effect as perceived by the sub-
ject. 
Effect of Adding Naloxone to the Clonidine and Fentanyl So-
lutions for Self-Administration of the Drug Mixture 
Narcotic antagonists are effective in preventing and 
reversing the pharmacological actions of opiates and can 
elicit narcotic-withdrawal in opiate-dependent organisms. 
Naloxone can be considered a relatively pure opiate antago-
nist which produces no discernable subjective effects when 
administered to non-opiate dependent subjects (Jaffe and 
Martin, 1975). 
As mentioned earlier, clonidine produces several pharma-
cological actions similar to narcotics. Therefore, it was 
of interest to examine the effect of naloxone on clonidine 
and fentanyl self-administration behavior. 
When added to the clonidine solution so that the sub-
jects received 64 ug/Kg/injection, naloxone did not decrease 
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rates of self-administration of rats previously self-ad-
ministering clonidine (15 ug/Kg/injection) alone. These 
findings are in agreement with the results of the recent stu-
dies of Paalzow and Paalzow (1976) and Fielding et al. (1977, 
in press) which derronstrate that clonidine-induced analgesia 
is not antagonized by naloxone. 
with the report of Meyer et al. 
They are also consistent 
(1977) who demonstrated that 
naloxone; in doses capable of suppressing operant behavior, 
causing body weight loss and other symptoms of withdrawal in 
morphine-dependent rats (Gellert and Sparber, 1977), failed 
to disrupt operant behavior in clonidine-dependent rats. 
Therefore, clonidine's reinforcing effects do not appear to 
be mediated through an interaction at the opiate receptor. 
In another study investigating the effect of a narcotic 
antagonist on the self-administration of a non-narcotic drug, 
Goldberg et al. (1972) reported that nalorphine had no effect 
on rates of cocaine self-administration in monkeys. 
Narcotic antagonists have been demonstrated to maintain 
responding that postpones or terminates their administration 
(i.e. to act as negative reinforcers) in morphine-dependent 
monkeys (Goldberg,1971,1972; Downs and Woods, 1975; Woods 
et al., 1975) and rats (Smith, 1973). In drug-naive animals 
narcotic antagonists with weak antagonistic properties such 
as pentazocine and propiram will maintain behavior leading 
to their administration (i.e. to act as positive reinforcers) 
(Woods and Villareal, 1970; Hoffmeister and Schlichting, 
1972; Goldberg et al., 1972) while narcotic antagonists with 
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strong antagonistic properties such as cyclazocine and nalor-
phine do not function as positive reinforcers (Deneau et al., 
1969; Hoffmeister and Schlichting, 1972) and may act as neg-
ative reinforcers (Hoffmeister and Wuttke, 1973) . 
Low doses of narcotic antagonists have been reported to 
increase morphine self-administration (Weeks and Collins, 
1964; Thompson and Schuster, 1964; Goldberg et al., 1969, 
1971, 1972) while high doses decrease responding to obtain 
morphine injections (Goldberg et al., 1972). Furthermore, 
narcotic antagonists have been demonstrated to block the 
ability of narcotics to impart secondary reinforcing proper-
ties on previously neutral stimuli (Davis and Smith, 1974; 
Marcus et al., 1976). 
When naloxone was added to the fentanyl solution so 
that the subjects received 64 ug/Kg/injection there was a 
significant decrease in the self-administration rates of 
rats previously self-administering fentanyl (1 ug/Kg/injec-
tion) alone. Response rates remained significantly sup-
pressed below pre-naloxone rates while naloxone remained in 
the fentanyl solution but gradually returned toward pre-
naloxone rates when naloxone was removed from the fentanyl 
solution. Similar results were obtained by Woods et al. 
(1975) who examined the effect of response-contingent nalox-
one injections on codeine-reinforced responding in rhesus 
monkeys. Naloxone produced a dose-dependent decrease in 
codeine-reinforced responding when added to the codeine 
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solution for self-administration of the codeine-naloxone 
mixture. Furthermore, codeine-reinforced responding re-
mained suppressed while naloxone remained in the codeine 
solution and gradually returned to pre-naloxone rates over 
three sessions following removal of naloxone. Woods et al., 
(1975) suggest that response-contingent naloxone injections 
function as a punishing stimulus which decreases self-
administra tion (lever pressing) behavior. Since almost 
identical results were obtained in this and the Woods et 
al. study, decreased fentanyl-reinforced responding follow-
ing addition of naloxone to the fentanyl solution may also 
be explained by the punishing effects of response-contingent 
naloxone injections. 
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Effect of Adding Some Butyrophenone to the Clonidine and 
Fentanyl Solution for Self-Administration of the Drug Mix-
t~e 
1. Haloperidol 
Chemically, haloperidol is the prototype of the buty-
rophenone series of neuroleptic compounds (Janssen, 1967). 
The ED 50 values for haloperidol in the norepinephrine and 
amphetamine antagonism tests in rats are 2.10 and 0.38 
mg/Kg, respectively (Janssen and Van Bever, 1978). Thus 
haloperidol is an extremely potent antagonist of dopamine 
receptors, a property which affords this drug tremendous 
efficacy in the treatment of psychoses. 
Hanson and Cimini-Venema (1972) reported that low doses 
of haloperidol (0.6 mg/Kg, twice daily) increased morphine 
self-administration in rats while doses of 0.24 mg/Kg and 
higher, twice daily, significantly decreased morphine self-
administration. Similarly, Pozuelo and Kerr (1972) re-
ported that haloperidol decreased morphine intake in morphine-
dependent monkeys and Glick and Cox (1975) reported a dose-
related antagonism of morphine self-administration produced 
by haloperidol. Utilizing a conditioned reinforcement test, 
Smith and Davis (1975) demonstrated that haloperidol-induced 
decreases in morphine self-administration was the result of 
a motor deficit and was not the result of antagonism of the 
reinforcing action of morphine. However, investigations of 
the effects of neuroleptics on psychomotor stimulant self-
administra tion (Davis and Smith, 1975; Yokel and Wise, 
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1975, 1976) indicate that neuroleptics attenuate the rein-
forcing effects of this class of drugs at doses which do 
not produce motor deficits. 
The results of these studies suggest that haloperidol 
and other neuroleptics may have potential value in the 
treatment of narcotic and psychomotor stimulant abuse. This 
suggestion is supported by the finding that amphetamine 
euphoria is reduced after pimozide, a diphenulbutylpiperi-
dine neuroleptic (Janssen et al., 1968), administration to 
humans (Gunne et al., 1972). Furthermore, Karkalas and Lal 
(1973) reported that haloperidol suppressed heroin absti-
nence and reduced craving for the drug. 
Lever pressing rates of rats previously self-administer-
ing clonidine (15 ug/Kg/injection) or fentanyl (1 ug/Kg/ 
injection) alone significantly decreased when haloperidol 
was added to the clonidine and f entanyl solutions so that 
the subjects received 64 ug/Kg/injection. The addition of 
haloperidol did not preferentially affect clonidine- or 
fentanyl-reinforced responding; rather, haloperidol pro-
duced a similar reduction in lever pressing when added to 
either drug solution. Suppression of clonidine- and 
fentanyl-reinforced responding remained stable while halo-
peridol remained in the drug solutions. Clonidine- and 
fentanyl-reinforced responding tended to return to pre-
haloperidol rates upon removal of haloperidol from both 
drug solutions; however, the number of subjects was too 
small to determine statistical significance. 
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Unfortunately, all of the animal studies cited above 
measured the effect of subcutaneous or intraperitoneal ad-
ministration of neuroleptics on narcotic and psychomotor 
stimulant self-administration, whereas making a direct com-
parison between the effect of adding the neuroleptic halo-
peridol to the clonidine and fentanyl solutions is diff i-
cult. The addition of haloperidol to the clonidine and 
fentanyl solutions could have decreased response rates in 
rats previously self-administering clonidine and fentanyl 
alone for several reasons. 
Investigations of the neurochemical basis for reinforce-
ment resulting from the self-administration of narcotics 
(Davis and Smith, 1972; Davis and Smith, 1973a; Glick et 
al., 1973) and psychomotor stimulants (Davis and Smith, 
1972; Davis and Smith, 1973b) have implicated central cate-
cholaminergic brain mechanisms. Attempts to discriminate 
between brain noradrenergic and dopaminergic mechanisms 
suggest the involvement of noradrenergic receptors in opi-
ate reinforcement (Davis et al., 1975), while both nora-
drenergic and dopaminergic receptors appear to be involved 
in psychomotor stimulant reinforcement (Davis et al., 1975; 
Davis and Smith, 1975). In view of the known anti-cate-
cholaminergic activity of haloperidol it could be suggested 
that decreased self-administration rates in rats previously 
self-administering either clonidine or fentanyl alone ~e 
the result of attenuation of the reinforcing property under-
lying the action of these drugs. 
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Neuroleptics are also known, however, to produce seda-
tion and motor deficits. Therefore, reduced lever pressing 
produced by haloperidol may be the result of a performance 
deficit. Wise (1978) has reviewed evidence showing that 
neuroleptics interfere with reward processes at doses that 
do not cause significant performance impairment. Wise 
states that "data from studies of intravenous stimulant re-
ward suggest the use of moment to moment analysis of the 
pattern of neuroleptic effects ... ". This type of analysis 
is to prevent the incorrect observations which can result 
~hen response rates are measured over an entire test ses-
sion. For example, Yokel and Wise (1975, 1976) reported 
that low doses of the neuroleptic drugs pimozide and 
(+)butaclamol increased lever pressing for intravenous 
amphetamine injections. Higher doses produced an initial 
increase in lever-pressing followed by cessation of respond-
ing. The authors suggest that low doses of neuroleptics 
decrease the rewarding effects of amphetamine and that 
subjects increase lever pressing to overcome the neurolep-
tic attenuation of the rewarding effects. Higher doses 
were suggested to completely block the rewarding effects 
and thus following an initial extinction burst, gradual 
extinction of lever pressing is observed. A respons,e 
pattern similar to the latter occurs when saline is substi-
tuted for a drug reinforcer. Had response rates been 
averaged over the entire session, however, Yokel and Wise 
would not have made the same observations since response 
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rates in these studies were depressed over the entire test 
session. Since the effect of adding haloperidol on lever 
pressing rate in rats previously self-administering either 
clonidine or f entanyl alone was measured over a 24 hour 
period an initial increase in response rate (an indicator 
of reward attenuation) would have been masked, therefore 
it cannot be stated with certainty whether or not haloperi-
dol was decreasing the reinforcing property of clonidine 
and fentanyl or was producing sedation and motor deficits. 
Finally, by definition, punishment is said to have 
occurred when the future probability of behavior that pre-
cedes the delivery of the punishing stimulus is reduced 
(Azrin and Holz, 1966). Therefore, the addition of haloper-
idol to the clonidine and fentanyl solutions could have 
produced a punishing (aversive) stimulus which resulted in 
the reduction of lever pressing so observed. 
2. Aceperone 
Aceperone is a butyrophenone neuroleptic which is 
virtually devoid of anti-dopaminergic activity (Janssen 
et al., 1967; Janssen, 1978) and should be considered as 
a specific alpha-adrenergic blocking agent and not as an 
antipsychotic (Janssen and Van Bever, 1978). ED50 values 
for aceperone in the norepinephrine and amphetamine antago-
nism tests in rats are 0.60 and 160 mg/Kg, respectively 
(Janssen and Van Bever, 1978). 
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When aceperone was added to the clonidine solution, 
so that the subjects received 64 ug/Kg/injection, no sig-
nificant change in the rates of self-administration of 
rats previously self-administering clonidine (15 ug/Kg/ 
injection) alone was observed. As discussed earlier, the 
marked sympathomimetic signs exhibited by rats self-ad-
ministering clonidine and results of other investigators 
suggested that the reinforcing action of clonidine was 
mediated by an interaction of post-synaptic alpha-noradren-
ergic receptors. Therefore, one would expect that the 
alpha-noradrenergic receptor antagonist, aceperone , would 
have some effect on the reinforcing effects of clonidine. 
Braestrup (1974) reported that aceperone produced a sig-
nificant increase in the brain concentration of the major 
norepinephrine metabolite, 3-methoxy-4-hydroxy-phenyl-
glycol (MOPEG) , while clonidine significantly decreased 
MOPEG concentration. It is suggested by Braestrup (1974) 
that aceperone increases release of norepinephrine while 
clonidine decreases norepinephrine release. 
Aceperone- and clonidine-induced changes in norepine-
phrine release may be accomplished by two mechanisms. 
Blockade of either pre- or post-synaptic alpha-noradrenergic 
receptors by aceperone would lead to increased norepinephrine 
release while stimulation of either pre~ or post-synaptic 
receptors by clonidine would lead to a decrease in nore-
pinephrine release. Thus, if clonidine were stimulating 
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post-synaptic receptors and aceperone were blocking post-
synaptic receptors one would expect antagonism of the re-
inforcing action of clonidine by aceperone. However, if 
clonidine were stimulating post-synaptic receptors and 
aceperone were blocking pre-synaptic receptors, no antago-
nism would be expected. In fact, the latter mechanism 
could be hypothesized to result in potentiation of the 
reinforcing action of clonidine. The differential affinity 
of aceperone for the pre- and post-synaptic alpha-adrener-
gic receptors is not known. It may also be suggested that 
both drugs are acting at the post-synaptic receptor but 
the dose of aceperone is insufficient to antagonize cloni-
dine' s agonist action. Clearly, more work is needed to 
investigate these results. The use of other alpha-adren-
ergic receptor blockers with differential actions at the 
pre- and post-synaptic such as piperoxane and phenoxy-
benzamine would be of interest. 
When aceperone was added to the f entanyl solution so 
that the subjects received 64 ug/Kg/injection a signifi-
cant (approximately two-fold) increase in the response 
rates of rats previously self-administering fentanyl (1 ug/Kg/ 
injection) alone was observed. The rates of self-adminis-
tration remained fairly stable and significantly above pre-
aceperone rates, while aceperone remained in the fentanyl 
solution. These results could be interpreted in two ways. 
As mentioned earlier, low doses of neuroleptics are reported 
to increase narcotic and psychomotor-stimulant self-
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administration, while higher doses produce an initial in-
crease in responding followed by a decrease in drug self-
adminis tration (Hanson and Cimini-Venema, 1972; Yokel and 
Wise, 1975, 1976). It was suggested that low doses of 
neuroleptics produce a partial blockade of the reinforcing 
actions of these drugs and thus subjects increase rates of 
self-administration to overcome the attenuation, while 
higher doses produce complete blockade of the reinforcing 
effects which after an extinction burst leads to extinction 
of the self-administration behavior. Since the noradrener-
gic system has been implicated in mediating the reinforcing 
actions of narcotics (Davis and Smith, 1975), blockade of 
alpha-noradrenergic receptors by aceperone could lead to 
attenuation of the reinforcing action of fentanyl and thus 
subjects increase lever pressing to overcome the aceperone 
action. If this interpretation is correct, then increasing 
the dose of aceperone added to the fentanyl solution should 
eventually produce complete blockade of the reinforcing 
effects of fentanyl and thus extinction of fentanyl self-
administration. 
An alternative interpretation, however, is that adding 
aceperone to the fentanyl solution makes the drug combi-
nation more reinforcing than fentanyl alone. Again, 
Braestrup (1974) suggested that aceperone increase norepine-
phrine release. This action could be seen to potentiate 
the reinforcing actions of narcotics which are suggested to 
be mediated through the noradrenergic system (Davis and 
Smith, 1975). 
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The latter interpretation may explain the increase 
in response rate observed when aceperone was removed from 
the fentanyl solution. Weeks and Collins (1964) reported 
that in physiologically dependent rats, self-administer-
ing morphine reducing the injection dose resulted in an 
increase in the number of injections taken. Thus if add-
ing aceperone to the fentanyl solution increases the rein-
forcement per injection then decreasing the reinforcement 
per injection by removing aceperone fromthefentanyl so-
lution could result in a compensatory increase in lever 
pressing such as was observed. It should be noted, how-
ever, that a sufficient number of subjects to determine 
statistical significance of post-aceperone data was not 
achieved. 
3. Azaperone 
Azaperone is a sedative neuroleptic of the butyrophen-
one series with outstanding anti-aggressive and anti-shock 
activity in animals (Niemegeers et al., 1974). The effec-
tive dose 50 (Eo 50 ) for azaperone in the norepinephrine 
antagonism test (a measure of anti-noradrenergic activity) 
in rats is 0.33 mg/Kg while the ED50 value for azaperone 
in the amphetamine antagonism test (a measure of anti-
dopaminergic activity) in rats is 2.5 mg/Kg (Niemegeers 
et al., 1974; Janssen and Van Bever, 1978). Therefore, 
azaperone is a more potent antagonist of noradrenergic re-
ceptors than of dopaminergic receptors. 
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Lever pressing rates of rats previously self-adminis-
tering either clonidine (15 ug/Kg/injection) or fentanyl 
(1 ug/Kg/injection) tended to decrease when azaperone was 
added to the respective drug solutions so that the sub-
jects received 64 ug/Kg/injection. Addition of azaperone 
did not preferentially affect clonidine- or fentanyl-rein-
forced responding; rather, azaperone tended to produce a 
similar reduction in lever pressing when added to either 
drug solution. Suppression of clonidine- and fentanyl-
reinforced responding remained stable while azaperone re-
mained in the drug solutions. Fentanyl- and clonidine-
reinforced responding tended to return to pre-azaperone 
rates when azaperone was removed from the clonidine and 
fentanyl solutions. It should be noted however, that the 
number of subjects was too small to determine a statisti-
cal significance. 
Like haloperidol, the addition of azaperone to the 
clonidine and fentanyl solutions may result in a decrease 
in response rates for three reasons. First, azaperone 
could antagonize the reinforcing actions of clonidine and 
fentanyl which leads to the observed decrease in self-
administra tion behavior. Since azaperone is a potent 
catecholamine receptor antagonist non-specific motor defi-
cits produced by the drug could produce the decreased 
response rates. Again, since response rate was measured 
over a 24-hour period one cannot determine whether azaperone 
decreased the rewarding action of clonidine and fentanyl as 
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as an initial increase in lever pressing (an indicator 
of reward attenuation) would have been masked. 
Neuroleptics of the butyrophenone- and phenothiazine-
type are well known to produce dysphoric effects in non-
schizophrenic human beings (Janke and Debus, 1968). Fur-
thermore, both types of neuroleptics have been demonstrated 
to maintain behavior leading to their termination or non-
occurrence (i.e. to act as negative reinforcers) in rhesus 
monkeys (Hoffmeister, 1975; Hoffmeister and Wuttke, 1975; 
Hoffmeister, 1977). Therefore, perhaps the best explana-
tion for the decreased response rates observed is that the 
addition of azaperone to the clonidine and fentanyl solu-
tions forms a punishing stimulus which results in a reduc-
tion in lever pressing behavior. 
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SUMMARY AND CONCLUSIONS 
In summary it was demonstrated that laboratory rats 
will self-administer the alpha-noradrenergic receptor ago-
nist clonidine when a dose of 15 ug/Kg/injection is made 
contingent on a continuous reinforcement schedule. That 
clonidine was self-administered for its positive reinforc-
ing property and not because of the drug's non-specific 
behavioral effects was demonstrated by an increase in the 
response rate to obtain clonidine injections as the re-
sponse requirement to obtain each clonidine injection was 
increased. 
It was also demonstrated that rats will self-adminis-
ter fentanyl (1 but not 0.1 ug/Kg/injection). Extinction 
of self-administration behavior in rats self-administering 
fentanyl following the substitution of saline for the 
fentanyl solution indicates that fentanyl was self-adminis-
tered for its positive reinforcing effects. 
In rats self-administering fentanyl (1 ug/Kg/injection), 
it was demonstrated that substitution of clonidine (15 but 
not 1 ug/Kg/injection) for the fentanyl solution maintained 
self-administration behavior. 
Pilot experiments demonstrated that addition of the 
narcotic antagonist naloxone to the clonidine and fentanyl 
solutions resulted in a significant decrease in fentanyl-
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reinforced responding but did not appear to decrease cloni-
dine-reinforced responding. These data suggest that 
clonidine reinforcement is mediated by opioid independent 
mechanisms. Preliminary experiments also demonstrated that 
addition of haloperidol and azaperone to the clonidine and 
fentanyl solutions tended to result in a decrease in cloni-
dine- and fentanyl-reinforced responding; however, the 
exact nature of this effect was unclear. Similarly, in a 
pilot experiment it was determined that addition of aceper-
one to the clonidine and fentanyl solutions had no effect 
on clonidine-reinforced responding but resulted in a two-
fold increase in fentanyl-reinforced responding. The 
exact basis of these results remains to be determined. 
In conclusion, self-administration of the alpha-nor-
adrenergic receptors agonist clonidine and increased self-
administration rates to obtain clonidine injections as the 
response requirement to obtain each clonidine injection was 
increased suggests that stimulation of alpha-noradrenergic 
receptors can result in positive reinforcement. All drugs 
that are abused by humans are self-administered by labor-
atory animals and most drugs that are self-administered by 
laboratory animals are self-administered by man. There-
fore, intravenous self-administration of clonidine by rats 
suggests that clonidine may possibly possess abuse poten-
tial by humans if self-administered intravenously. Also, 
because of the known abuse of narcotics by humans, main-
tainence by clonidine of self-administration behavior of 
112 
rats previously self-administering the synthetic narcotic 
fentanyl supports this suggestion. 
Preliminary experiments suggest that fentanyl- and 
clonidine-reinf orced responding are similarly affected by 
the addition of haloperidol and azaperone to the fentanyl 
and clonidine solutions. However, the exact nature of 
these effects remains to be determined. Furthermore, pre-
liminary experiments with aceperone suggest that fentanyl-
and clonidine-reinforced responding are affected differ-
entially by the addition of aceperone to the fentanyl and 
clonidine solutions. Finally, decreased fentanyl- but 
not clonidine-reinforced responding by response-contingent 
naloxone injections suggests that clonidine reinforcement 
is not mediated by opioid dependent mechanisms. 
113 
REFERENCES 
Aghajanian, G.K. and Bunney, B.S.: Pharmacological charac-
terization of dopamine "autoreceptors" by microionto-
phonetic sing-ecell recording studies. In Nonstriatal 
Dopaminergic Neurons, edited by E. Costa and G. L. 
Gessa, pp. 433-438 , Raven Press, New York, 1977. 
Ahlenius, S., Anden, N.E., and Engel, J.: Importance of 
catecholamine release by nerve impulses for free oper-
ant behavior. Physiol. Behav. 7: 931-934, 1971. 
Anden, N.E., Dahlstrom, A., Fuxe, K. and Larsson, K.: Func-
tional role of the nigro-neostriatal dopamine neurons. 
Acta Pharrnacol. Toxicol. 24: 263-274, 1966. 
Anden, N.E., Corrodi, H., Fuxe, K. and Hokfelt, T.: Evi-
dence for a central 5-hydroxytryptamine receptor 
stimulation by lysergic acid diethylamide. Brit. J. 
Pharrnacol. 34: 1-7, 1968. 
Anden, N.E., Corrodi, H., Fuxe, K., Hokfelt, B., Rydin, C. 
and Svensson, T.: Evidence for a central noradrenaline 
receptor stimulation by clonidine. Life Sci. 9: 
513-523, 1970. 
Anden, N.E., Butcher, S.G. and Engel, J.: Central dopamine 
and noradrenaline receptor activity of the amines 
formed from m-tyrosine, alpha-methyl-m-tyrosine and 
alpha-methyl dopa. J. Pharm. Pharmacol. 22: 548-550, 
1970a. 
Anden, N.E., Strombom, u. and Svensson, T.H.: Dopmaine and 
noradrenaline receptor stimulation: Reversal of 
reserpeine-induced suppression of motor activity. 
Psychopharmacologia 29: 289-298, 1973. 
Anden, N.E., Gabrowska, M. and Strombom, u.: Different alpha-
adrenoceptors in the central nervous system mediating 
the biochemical and functional effects of clonidine and 
receptor blocking agents. Nauryn-Schmiedebergs 
Archives Pharmacologia 292: 43-52, 1976. 
Anderson, W.W. and Thompson, J.: Ethanol self-administration 
in water satiated rats. Pharmacol. Biochem. Behav. 2: 
447-454, 1974. 
Azrin, N.H. and Holz, W.C.: Punishment. In: Operant Behavior: 
Areas of research and application, edited by W.K. Honig 
pp. 380-447 , Appleton-Century-Crofts, New York, 1966. 
114 
Balster, R.L. and Schuster, C.R.: Fixed-interval schedule 
of cocaine reinforcement: effect of dose and infusion 
duration. J. of Exp. Anal. Behav. 20: 119-129, 1973. 
Baxter, B.L., Gluckman, M.I., Stein, L. and Scerri, R.A.: 
Self-injection of apomorphine in the rat: positive 
reinforcement by a dopamine receptor stimulant. 
Pharrnacol. Biochem. Behav. 2: 387-391, 1974. 
Belluzi, J.D., Ritter, S., Wise, C.D., Stein, L.: Substania 
nigra self-stimulation: dependence on noradrenergic 
pathways. Behav. Biol. 13: 103-111, 1975. 
Bentley, G.A., Copeland, I.W. and Starr, J.: The actions 
of some alpha-adrenoceptor agonists and antagonists 
in an antinociceptive test in mice. Clin. Exp. Pharrnacol. 
Physiol. 4: 405-419, 1977. 
Bill, A. and Heilmann, K.: Ocular effects of clonidine in 
cats and monkeys (Macacu irus). Exp. Eye Res. 21: 
481-488, 1975. 
Bjonkqvist, S.E.: Clonidine in alcohol withdrawal. Acta 
Psychiat. Scand. 52: 256-263, 1975. 
Boissier, J.R., Gindialli, J.F., Fichelle, J., Schmitt, H. 
and Schmitt, H.: Cardiovascular effects of 2-(2,6-di-
chlorophenylamine)-2-imidazole (St 155). Europ. J. 
Pharmacol. 2: 333-339, 1968. 
Braestrup, C.: Effects of phenoxybenzamine aceperone and 
clonidine on the level of 3-methoxy-4-hydroxy-phenyl-
glycol (MOPEG) in ratbrain. J. Pharrn. Pharmacol. 26: 
139-141, 1974. 
Bullock, S.A., Kruse, H., and Fielding, S.: The effect of 
clonidine .on conflict behavior in rats: is clonidine 
an anxiolytic agent? Pharmacologist 20: 223, 1978. 
Burks, T.F.: Central alpha-adrenergic receptors in thermo-
regulation. Neuropharmacol. 11: 615-624, 1972. 
Cedarbaum, J.M. and Aghajanian, G.K.: Noradrenergic neurons 
of the locus coeruleus: inhibition by epinephrine and 
activation by th~-antagonist piperoxane. Brain Res. 
112: 413-419, 1976. 
Cedarbaum, J.M. and Aghajanian, G.K.: Catecholaminergic 
receptors on locus coeruleus neurons: pharmacological 
characterization. Eur. J. Pharmacol. 44: 375-385, 1977. 
115 
Colelli, B., Meyer, D.R. and Sparber, S.B.: 
nizes disruption of fixed ratio operant 
morphine pelleted rats given naloxone. 
18: 236, 1976. 
Clonidine antago-
behavior in 
Pharmacologist 
Constantine, J.W. and Mcshane, W.K.: Analysis of the cardio-
vascular effects of 2-(2,6-dichlorophenylarnine)-2-
imidazoline hydrochloride (Catapresan). Eur. J. Pharm. 
4: 109-123, 1968. 
Cornfeldt, M.L., Fielding, S., Kruse, H., Billey-Nichuck, J., 
Dobson, c. and Wilker, J.: Clonidine: inhibition of 
amphetamine-induced circling and other psychopharmaco-
logical effects. Pharmacologist 20: 162, 1978. 
Cubeddu, L., Barnes, F.M., Langer, S.Z. and Weiner, N.: 
Release of norepinephrine and dopamine-!J-hydroxylase 
by nerve stimulation. 1. Role of neuronal and extra-
neuronal uptake ofQ(..-presynaptic receptors. J. Pharmacol. 
Exp. Ther. 190: 431-450, 1974. 
Dahlstrom, A. and Fuxe, K.: Evidence for the existence of 
monamine-containing neurons in the central nervous 
system. I. Demonstration of monoamines in the cell 
bodies of brain stem neurons. Acta Physiologica Scand. 
62: 1-55, 1965. 
Davis, W.M. and Smith, S.G.: Alpha-methyl-tyrosine to prevent 
self-administration of morphine and amphetamine. 
Curr. Ther. Res. 14: 814-819, 1972. 
Davis, W.M. and Smith, S.G.: Blocking of morphine based 
reinforcement by alpha-methyltyrosine. Life Sci. 12: 
185-191, 1973a. 
Davis, W.M. and Smith, S.G.: Blocking effect of alpha-
methyltyrosine on amphetamine based reinforcement. J. 
Pharm. Pharmacol. 25: 174-177, 1973b. 
Davis, W.M. and Smith, S.G.: Noradrenergic basis for rein-
forcement associated with morphine action in nondependent 
rats. In Drug Addiction, Vol. 3, pp. 155-168 , 
edited by J.M. Singh and H. Lal, Symposia Specialists, 
Miami, 1974. 
Davis, W.M. and Smith, S.G.: Naloxone use to eliminate opiate-
seeking behavior: need for extinction of conditioned 
reinforcement. Biol. Psychiat. 9: 181-189, 1974a. 
Davis, W.M., Smith, S.G. and Khalsa, J.H.: Noradrenergic role 
in the self-administration ·of morphine and amphetamine. 
Pharmacol. Biochem. Behav. 3: 477-484, 1975. 
116 
Davis, W.M. and Smith, S.G.: Effect of haloperidol on 
(+)amphetrnaine self-administration. J. Pharrn. Pharmacol. 
27: 540-542, 1975. 
Delbarre, B. and Schmitt, H.: Sedative effects of alpha-
sympathomirnetic drugs and their antagonism by adrenergic 
and cholinergic blocking drugs. Eur. J. Pharrnacol. 13: 
356-363, 1971. 
Deneau, G., Yangita, T. and Seevers, M.H.: Self-administra-
tion of psychoactive substances by the monkey. A 
measure of psychological dependence. Psychopharma-
cologia 16: 30-48, 1969. 
Dix, R.K. and Johnson, E.M.: Withdrawal syndrome upon cessa-
tion of chronic clonidine treatment in rats. Eur. J. 
Pharmacol. 44: 153-159, 1977. 
Donaldson, I., Dolphin, A., Jenner, P., Marsden, C.D. and 
Pycock, C.: The roles of noradrenaline and dopamine 
in contraversive circling behavior seen after unilateral 
electrolytic lesions of the locus coeruleus. Eur. J. 
Pharmacol. 39: 179-191, 1976. 
Dougherty, J. and Pickens, R.: Fixed-interval schedules of 
intravenous cocaine presentation in rats. J. Anal. 
Behav. 20: 111-118, 1973. 
Downs, D.A. and Woods, J.H.: Codeine-and cocaine-reinforced 
responding in rhesus monkeys: effects of dose on response 
rates under a fixed-ratio schedule. J. Pharmacol. Exp. 
191: 179-188, 1974. 
Downs, D.A. and Woods, J.H.: Fixed-ratio escape and avoid-
ance escape from naloxone in morphine-dependent 
monkeys: effects of naloxone dose and morphine pretreat-
ment. J. Exp. Anal. Beh. 23: 415-427, 1975. 
Farnebo, L.O. and Hamberger, B.: Drug ·- induced changes in the 
release of 3H-monoamine from field stimulated rat brain 
slices. Acta Physiologica Scana. : 35-44, 1971. 
Feldberg, W. and Myers, R.O.: Effects on temperature of amines 
injected into the cerebral ventricles. A new concept 
of temperature regulation. J. Physiol. 173: 226-237, 
1964. 
Fibiger, H.C.: Drugs and reinforcement mechanisms: a critical 
review of the catecholamine theory. Ann. Rev. Pharmacol. 
Tox. 18: 37-56, 1978. 
117 
Fielding, S., Wilker, J., Hynes, M., Szewzak, M., Novick, W. 
and Lal, H.: Antinociceptive and withdrawal actions of 
clonidine: A comparison with morphine. Fed. Proc. 36: 
1024, 1977. 
Fielding, S., Wilker, J., Hynes, M., Szewczak, M., Novick, W. 
and Lal, H.: A comparison of clonidine with morphine 
for antinociceptive and antiwithdrawal actions. J. 
Pharmac. Exp. Ther., in press. 
Florio, V., Bianchi, L. and Lonogo, V.G.: A study of the 
central effects of sympathomimetic drugs: EEG and be-
havioral investigations of clonidine and naphazoline. 
Neuropharmacol. 14: 707-714, 1975. 
Franklin, K.B.J. and Herberg, L.J.: Self-stimulation and 
catecholamines. Drug-induced mobilization of the 
'Reserve'-pool re-established responding in catechola-
mine-depleted rats. Brain Res. 67: 429-437, 1974. 
Franklin, K.B.J. and Herberg, L.J.: Presynaptic~ -adreno-
ceptors: The depression of self-stimulation by clonidine 
and its restorationby piperoxane but not by phentolamine 
or phenoxybenzamine. Eur. J. Pharma. 43: . 33-38, 
1977. 
Gazzani, J.L. and Izquierdo, I.: Possible peripheral adrener-
gic and central dopaminergic influences on memory consoli-
dation. Psychopharmacology 49: 109-112, 1976. 
Gellert, V.F. and Sparber, S.B.: A comparison of the effects 
of naloxone upon body weight loss and suppression of 
fixed-ratio operant behavior in morphine-dependent rats. 
J. Pharmacol. Exp. Ther. 201: 44-54, 1977. 
German, D.C. and Bowden, D.M.: Catecholamine systems as the 
neural substrate for intracranial self-stimulation: a 
hypothesis. Brain Res. 73: 381-419, 1974. 
Gianutsos, G., Hynes, M.D. and Lal, H.: Enhancement of mor-
phine-withdrawal and apomorphine-induced aggression 
by clonidine. Psychopharm. Comm. 2: 165-171, 1976. 
Glick, S.D., Zirnmerberg, B. and Charap, A.D.: Effects of 
alpha-methyl-para-tyrosine on morphine dependence. 
Psychopharmacology 32: 365-371, 1973. 
Glick, S.D. and Cox, R.D.: Doparninergic and cholinergic 
influences on morphine self-administration in rats. 
Res. Comm. Cl in. Pathol. Pharmacol. 12: 17-24, · 19 7 5. 
Glick, S.D. and Cox, R.: Differential sensitivity to apomor-
phine and clonidine following frontal cortical damage in 
rats. Eur. J. Pharmacol. 36: 241-245, 1976. 
118 
Gogoak, V.G. and Stumpf, Ch.: The effects of 2-(2,6-di-
chlorophenylamino)-2-imidazoline hy drochloride on the 
EEG-arousal reaction in rabbits. Arzneim. Forsch. 16: 
1050-1052, 1966. 
Gold, M.S., Redmond, D.E. Jr. and Kleber, H.D.: Clonidine 
in opiate withdrawal. Lancet 1: 929-930, 1978. 
Goldberg, S.R., Woods, J.H. and Schuster, C.R.: Morphine: 
Conditioned increases in self-administration in rhesus 
monkeys. Science. 166: 1306-1307, 1969. 
Goldberg, S.R., Woods, J.H. and Schuster, C.R.: Nalorphine-
induced changes in morphine self-administration in rhesus 
monkeys. J. Pharmacol. Exp. Ther. 176: 464-471, 197la. 
Goldberg, S.R., Hoffmeister, F., Schlichting, U.U. and Wuttke, W. 
Aversive properties of nalorphine and naloxone in mor-
phine-dependent rhesus monkeys. J. Pharmacol. Exp. Ther. 
179: 268-276, 197lb. 
Goldberg, S.R., Hoffmeister, F., Schlichting, u.v. and Wuttke, 
W.: A comparison of pentobarbital and cocaine self-
administration in rhesus monkeys: effects of dose and 
fixed-ratio parameter. J. Pharmacol. Exp. Ther. 179: 
277-283, 197lc. 
Goldberg, S.R., Hoffmeister, F. and Schlichting, U.U.: 
Morphine antagonists: modification of behavioral effects 
of morphine dependence. In Drug Addiction: I. Experimental 
Pharmacology edited by J.M. Singh, L. Miller and H. Lal 
pp. 31-48 , Futura Publishing Co., New York, 1972. 
Goldberg, S.R.: Comparable behavior maintained under fixed-
ratio and second-order schedules of food presentation, 
cocaine injection or d-amphetamine injection in the 
squirrel monkey. J. Pharmacol. Exp. Ther. 186: 18-30, 
1973. 
Goldberg, S.R., Kelleher,R.T. and Morse, W.H.: Second-order 
schedules of drug injection. Fed. Proc. 34: 1171-1176, 1975. 
Goldberg, S.R. and Kelleher, R.T.: Behavior controlled by 
fixed-interval, fixed-ratio and multiple schedules of 
cocaine injection in squirrel monkey s and rhesus monkeys. 
J. Exp. Anal. Behav. 25: 93-104, 1976. 
Gomes, C., Svensson, T.H. and Trolin, G.: Effects of morphine 
on central catecholamine turnover, blood pressure and 
heart rate in the rat. Nauyn-Schmeidebergs Arch. 
Pharmacol. 294: 141-147, 1976. 
119 
Gunne, L.M., Anggard, E., and Jonsson, L.E.: Clinical trials 
with amphetamine-blocking drugs. Psychiat. Neurol. 
Neurochirimie 75: 225-226, 1972. 
Hanson, H.M. and Cimini-Venama, C.A.: Effects of haloperidol 
on self-administration of morphine in rats. Fed. Proc. 
31: 503, 1972. 
Harris, R., Snell, D., Loh, H.H. and Way, E.L.: Behavioral 
interactions of apomorphine, clonidine and naloxone: 
possible pre-synaptic involvement. Proc. West. Pharmacol. 
Soc. 19: 448-451, 1976. 
Harris, R.A., Snell, D., Loh, H.H., and Way, E.L.: Behavioral 
interactions between naloxone and dopamine agonists. 
Pharmacol. 43: 243-246, 1977. 
Harvey, S.C.: 
Basis of 
and A.G. 
Co. 
Hypnotics and sedatives. In: The Pharmacological 
Experimental Therapeutics, edited by L.S. Goodman 
Gilman, 102-123 New York, Macmillan Publishing 
Hastings, L. and Stutz, R.M.: The effect of alpha- and beta-
adrenergic antagonists on the self-stimulation phenomenon. 
Life Sci. 13: 1253-1259, 1973. 
Herman, Z.S., Brus, R., Drybanski, A., Szkilnik, R. and 
Slominska-Zurek, J.: Influence of 6-hydroxydopamine on 
the behavioral effects induced apomorphine or clonidine 
in rats. Psychopharmacology 50: 73-80, 1976. 
Hoffmeister, F. and Schlichting, U.U.: Reinforcing properties 
of some opiates and opioids in rhesus monkeys with 
histories of cocaine and codeine self-administration. 
Psychopharmacologia 23: 55-74, 1972. 
Hoffmeister, F. and Wuttke, W.: Negative reinforcing proper-
ties of morphine antagonists in naive rhesus monkeys. 
Psychopharmacologia 33: 247-258, 1973. 
Hoffmeister, F.: Negative reinforcing properties of some 
psychotropic drugs in drug-naive rhesus monkeys. J. 
Pharmacol. Exp. Ther. 192: 468-477, 1975. 
Hoffmeister, F. and Wuttke, W.: Psychotropic drugs as nega-
tive reinforcers. Pharmacol. Rev. 27: 419-428, 1975. 
Hoffmeister, F.: Reinforcing properties of perphenazine, 
haloperidol and amitryptiline in rhesus monkeys. J. 
Pharmacol. Exp. Ther. 200: 516-522, 1977. 
Hoefke, W. and Kobinger, W.: Pharmacological effects of 
2-(2,6 dichlorophenylamino)-2-imidazoline hydrochloride, 
a new antihypertensive substance. Arzneim. Forsh. 16: 
1038-1050, 1966. 
120 
Holman, R.B., Shillito, E.E. and Vogt, M.: Sleep produced 
clonidine (2-(2,6-dichlorophonylamino)-2-imidazoline 
hydrochloride). Br. J. Pharmacol. 43: 685-695, 1971. 
Hunt, G.E., Atrens, D.M., Chechet, G.B., and Becker, F.T.: 
ol-Noradrenergic modulation of hypothalamic self-
stimulation: studies employing clonidine, 1-phenyle-
phrine ando(-methyl-p-tyrosine. E.ur. J. Pharmacol. 
37: 105-111, 1976. 
Hunyor, S.N., Bradstock, K., Somerville, P.J. and Lucas, N.: 
Clonidine overdose. Brit. Med. 4: 23, 1975. 
Iglaver, C. and Woods, J.H.: Concurrent performances: 
Reinforcement by different doses of intravenous cocaine 
in rhesus monkeys. J. Exp. Anal. Behav. 22: 179-196, 
19 74. 
Jaffe, J.H. and Martin, W.R.: Narcotic analgesics and 
antagonists. In: The Pharmacological Basis of 
Therapeutics edited by L.S. Goodman and A. Gilman, 
pp. 245-283 , Macmillan Publishing Co., New York, 
1975. 
Jahn, U. and Mixich, G.: Wet dog shake behavior in normal 
rats elicited by benzylidenaminooxycarbonic acid 
derivatives. Psychopharmacologia, 46: 191-196, 1976. 
Janke, w. and Debus, G.: Experimental studies on anti-
anxiety agents with normal subjects: Methodological 
considerations and review of main effect. In. Psycho-
pharmacology: A Review of Progress, 1957-1967, edited 
by D.H. Efron, pp. 205-230, U.S. Government Printing 
Office, Washington, D.C., 1968. 
Janssen, P.A.J.: The pharmacology of haloperidol. Int. 
J. Neurophsychiat. 3: 10-18, 1967. 
Janssen, P., Niemegeers, C., Schellekens, K. and Lenaerts, 
F.: Is it possible to predict clinical effects of 
neuroleptic drugs (major tranquilizers) from animal 
data? Arzneim. Forsch. Drug Res. 17: 841-854, 1967. 
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L., 
Dresse, A., Lenaerts, F.M., Pinchard, A., Shaper, 
W.K.A., Van Neuten, J.M. and Verbruggen, F.J.: 
Pimozide, a chemical novel, highly potent and orally 
long-acting neuroleptic drug. 1. The comparative 
pharmacology of pimozide, haloperidol, and chlor-
promazine. Arzneim~ForschDrug Res. 18: 261-279, 1968. 
121 
Janssen, P.A.J. and Ven Bever, W.F.M.: Structure-activity 
relationships of the butyrophenones and diphenylbutyl-
piperidines. In: Handbook of Psychopharmacology 
Vol. 10 edited by L. Iversen, S. Iversen, and S. 
Snyder, pp. 1-35 , Plenum Press, New York, 1978. 
Jenner, P.G. and Pycock, C.J.: Interaction of clonidine 
with dopamine-dependent behaviors in rodents. Brit. 
J. Pharmacol. 58: 469, 1976. 
Jonsson, L.E., Gunne, L.M. and Anggard, E.: Effects of 
alpha-methyltyrosine in amphetamine-dependent sub-
jects. Pharmac. Clin. 27-29, 1969. 
Jonsson, L.E., Anggard, E. and Gunne, L.M.: 
intravenous amphetamine euphoria in man. 
Pharmacol. Ther. 12: 889-896, 1971. 
Blockade of 
Clin. 
Karkalas, J. and Lal, H.: A comparison of haloperidol with 
methadone in blocking heroin-withdrawal symptoms . 
Int. Pharrnacopsychiat. 8: 248-251, 1973. 
Karppanen, H.: Possible involvement of central histamine 
H2-receptors in the hypotensive effect of clonidine. 
Nature 259: 587-588, 1976. 
Kelleher, R.T. and Morse, W.H.: Escape behavior and 
punished behavior. Fed. Proc. 23: 808-817, 1964. 
Knapp, M.S. and Galloway, N.R.: Ocular reactions to beta-
blockers. Brit. Med. J. 1: 557, 1975. 
Kobinger, W. and Walland, A.: Investigations into the 
mechanism of the hypotensive effect of 2-(2,6-dichloro-
phenylamino)-2-imidazoline HCl. Eur. J. Pharmacol. 
2: 155-162, 1967. 
Korf, J., Bunney, B.S. and Aghanjanian, G.K.: Noradrenergic 
neurons: morphine inhibition of spontaneous activity. 
Eur. J. Pharmacol. 25: 165-169, 1974. 
Kuhar, M.J., Pert, C.B. and Snyder, S.H.: Regional distri-
bution of opiate receptor binding in monkey and human 
brain. Nature 245: 1447-450, 1973. 
Lal, H.: Morphine-withdrawal aggression. In: Methods in 
Narcotic Research, edited by S. Ehrenpreis and 
E.A. Neidle, pp. 149-169, Marcel Dekker, New York, 
1975. 
122 
Lal, H. (ed.): Discriminative stimulus properties of drugs, 
New York: Plenum Press, New '. York, 1977. 
Lal, H., Gianutsos, G. and Puri, S.K.: 
cotic analgesics with neuroleptics 
measures of dopaminergic activity. 
29-34, 19 75. 
Comparison of nar-
on behavioral 
Life Sci. 17: 
Lal, H. and Gianutsos, G.: Discriminable stimuli produced 
by narcotic analgesics. Psychopharmacol. Corrun. 2: 
311-314, 1976. 
Lal, H., Gianutsos, G. and Miksic, S.: Discriminable 
stimuli produced by analgesics. In: Discriminative 
Stimulus Properties of Drugs, edited by H. Lal 
pp. 23-45 ' , Plenum Press, New York, 1977. 
Lal, H., Kaplan, L., Numan, R. and Valentino, D.: Acqui-
sition and extinction of operant responding for 
intravenous injections of fentanyl in the rat. 
Corrun. Psychopharmacol. 1: 207-212, 1977. 
Laverty, R. and Taylor, K.M.: Behavioral and biochemical 
effects of 2-(2,6-dichlorophenylamino-2-imidazoline 
hydrochloride (ST 155) on the central nervous system. 
Brit. J. Pharmacol. 35: 253-264, 1969. 
Le Douarec, J.C., Schmitt, H. and Lucet, B.: Effect of 
clonidine and alpha-sympathomimetics on water intake 
in rats deprived of water. J. Pharmacol. (Paris), 
2: 435-444, 1971. 
Le Douarec, J.C., Schm~tt, H. and Lucet, B.: Effects of 
clonidine and other alpha-sympathomimetic agents on 
food intake: antagonism by adrenolytics. J. Pharmacol. 
(Paris) 3: 187-198, 1972. 
Lenard, L.G. and Beer, B.: Modification of avoidance be-
havior in 6-hydroxydopaimine-treated rats by stimulation 
of central noradrenergic and dopaminergic receptors. 
Pharmacol. Biochem. Behav. 3: 887-893, 1975. 
Maas, J.W., Hattox, S.E., Landis, D.H. and Roth, R.H.: 
The determination of a brain arteriovenous difference 
for 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) . 
Brain Res. 118: 167-173, 1976. 
Maj, J., Sowinska, H., Baran, L. and Kapturkiewicz, Z.: The 
effect of clonidine on locomotor activity in mice. 
Life Sci. 11: 483-491, 1972. 
Maj, J., Baran, L., Grabowska, M. and Sowinska, H.: Effect 
of clonidine on the 5-hydroxytryptomine and 5-hydroxy-
indole-acetic acid brain levels. Biochem. Pharmacol. 
22: 2679-2683, 1973. 
123 
Maj, J., Baran, L., Sowinska, H. and Zielinski, M.: The 
influence of cholinolytics on clonidine action. 
Pol. J. Pharmacol. 27: 17-26, 1975. 
Marcus, R., Carnathan, G., Meyer, R.E. and Cochin, J.: 
Morphine-based secondary reinforcement: Effects of 
different doses of naloxone. Psychopharmacol. 8: 
747- 750' 1976. 
Marley, E. and Nistico, Q.: Central effects of clonidine, 
2-(2,6-dichlorophenylamino)-2-imidazoline, hydro-
chloride in fowls. Brit. J. Pharmacol. 55: 459-473, 
1975. 
McEntee, W.J. and Mair, R.G.: Korsakoff's amnesia: A 
noradrenergic hypothesis. A.C.N.P. Abstracts, 1978. 
McKearney,J.W.: Maintenance of responding under a fixed-
interval schedule of electric shock-presentation. 
Sience 160: 1249-1251, 1968. 
McKearney, J.W.: Fixed-interval schedules of electric 
shock presentation: Extinction and recovery of per-
formance under different shock intensities and fixed-
interval durations. J. Exp. Anal. Behav. 12: 
301-313, 1969. 
McKearney, J.W.: Responding under fixed-ratio and multiple 
fixed-interval fixed-ratio schedules of electric shock 
presentation. J. Exp. Anal. Behav. 14: 1-6, 1970. 
McKenzie, G. M. : 
Brain Res. 
Apomorphine-induced aggression in the rat. 
34: 323-330, 1971. 
Menon, M.K., Clark, W.G. and Masvoka, D.T.: Possible in-
volvement of the central dopaminergic system in the 
antireserpine effect of LSD. Psychopharmacology 52: 
291-297' 1977. 
Meyer, D.R., El-Azhary, R., Bierer, D., Hanson, S.K., 
Robbins, M.S. and Sparber, S.B.: Tolerance and de-
pendence after chronic administration of clonidine 
to the rat. Pharmacol. Biochem. Behav. 7: 277-281, 
1977. 
Miksic, S., Shearman, G. and Lal, H.: Generalization stud 
with some narcotic and non-narcotic drugs in rats 
trained for morphine-saline discrimination. Psycho-
pharrnacology, in press. 
Moore, M.A. and Phillipi, P.: Clonidine overdose. Lancet. 
2: 694, 1976. 
124 
Morpurgo, C.: Aggressive behavior induced by large doses 
of 2-(2,6-dichlorphenylamino)-2-imidazoline hydro-
chloride (ST 155) in mice. Eur. J. Pharmacol. 3: 
374-377' 1968. 
Morse, W.H. and Kelleher, R.T.: Schedules using noxious 
stimuli. I.Multiple fixed-ratio and fixed-interval 
termination of schedule complexes. J. Exp. Anal. Behav. 
9: 267-290, 1966. 
Myers, R.D.: Central mechanisms in the hypothalamus medi-
ating eating and drinking in the monkey. Ann. N.Y. 
Acad. Sci. 157: 918-933, 1969. 
Nickerson, M. and Ruedy, J.: Antihypertensive agents and 
the drug therapy of hypertension. In: The Pharma-
cological Basis of Experimental Therapeutics, edited 
by L.S. Goodman and A.G. Gilman, pp. 705-726 , 
Macmillan Publishing Co., New York, 1975. 
Niemegeers, C.J.E., Van Neuten, J.M. and Janssen, P.A.J.: 
Azaperone, a sedative neurleptic of the butyrophenone 
series with pronounced anti-aggressive and anti-
shock activity in animals. Arzneim. Forsch. Drug Res. 
24: 1798-1806, 1974. 
Ozawa, H., Miyauchi, T. and Sugawara, K.: Potentiating 
effect of lithium chloride on aggressive behavior 
induced by nialamide plus L-dopa and by clonidine. 
Eur. J. Pharmacol. 34: 169-179, 1975. 
Paalzow, L.: Analgesia produced by clonidine in mice and 
rats. J. Pharm. Pharmacol. 26: 361-363, 1974. 
Paalzow, G. and Paalzow, L.: Clonidine antinocicpetive 
activity: effects of drugs influencing central mon-
aminergic and cholinergic mechanisms in the rat. 
Naunyn-Schmiediergs-Arch. Pharmacol. 292: 119-126, 
1976. 
Pickens, R. and Harris, C.: Self-administration of d-
amphetamine by rats. Psychopharmacologia 12: 
158-163, 1968. 
Pickens, R. and Thompson, T.: Cocaine reinforced behavior 
in rats: effects of reinforcement magnitude and 
fixed-ratio size. J. Pharmacol. Exp. Ther. 161: 
122-129, 1968. 
Pickens, R.: Self-administration of stimulants by rats. 
Int. J. Addiction 3: 215-221, 1968. 
125 
Pickens, R., Meisch, R.A. and Dougherty, J.A.: Chemical 
interactions in metnamphetarnine reinforcement. 
Psychol. Rep. 23: 1267-1270, 1968. 
Pickens, R. and Thompson, T.: Characteristics of stimulant 
drug reinforcement. In: Stimulus Properties of 
Drugs edited by T. Thompson and R. Pickens, pp. 
177-191 . Appleton-Century-Crofts, New York, 1971. 
Pickens, R. and Thompson, T.: Simple schedules of drug 
self-administration. In: Drug Addiction, Vol. 1, 
Experimental Pharmacology, edited by J.M. Singh, 
L. Miller, and H. Lal, 'pp. 107-120 ·, Futura, New York, 
1972. 
Poignant, J.C. and Rismondo, N.: Influence of the adminis-
tration of psychopharrnacological compounds on the 
take-up time of an alimentary material in the hamster 
and a study of the associated behavior. Psychopharm. 
43: 47-52, 1975. 
pozuelo, J. and Kerr, F.W.: Suppression of craving and 
other signs of dependence in morphine-addicted monkeys 
by administration of alpha-methyl-para-tyrosine. 
Mayo Clin. Proc. 47: 621-628, 1972. 
Pycock, C., Donaldson, I. MacG. and Marseden, C.D.: 
Circling behavior produced by unilateral lesions of 
the locus coeruleus in rats. Brain Res. 97: 317-323, 
1975. 
Pycock, C.J., Jenner, P.G. and Marsden, C.D.: The inter-
action of clonidine with dopamine-dependent behavior 
in rodents. Nauyn Schmied. Arch. Pharmacol. 297: 
133-141, 1977. 
Rand, M.J. and Wilson, J.: Mechanisms of the presser and 
depressor actions of SE 155 (2-(2,6-dichlorophenylamino)-
2-imidazoline hydrochloride, catapress. Eur. J. 
Pharmacol. 3: 27-33, 1968. 
Razzak, A., Fujiwara, M. and Veki, S.: Automutiliation 
induced by clonidine in mice. Eur. J. Pharmacol. 
30: 356-360, 1975. 
Razzak, A., Fujiwara, M., Oishi, R., and Veki, S.: 
involvement of a central noradrenergic system 
automutilation induced by clonidine in mice. 
J. Pharmacol. 27: 145-152, 1977. 
Possible 
in 
Jap. 
Rech, R.H. and Moore, K.E.: An Introduction to Psycho-
pharmacology. Raven Press, New York, 1971. 
126 
Redmond, D.E., Jr., Huang, Y.H., Snyder, D.R., and Maas, 
J.W.: Behavioral effects of stimulation of the nucleus 
locus coeruleus in the stump-tailed monkey (Macaca 
arctoides). Brain Res. 116: 502-510, 1976. 
Redmond, D.E., Jr.: Alterations in the function of the 
nucleus locus coeruleus: a possible model for stu-
dies of anxiety. In: Animal Models in Psychiatry and 
Neurology edited by I. Hanin and E. Usdin, pp. 293-
305 , Pergamon Press, Oxford, 1977. 
Reid, J.L., Lewis, P.J. and Meyers, M.G.: Role of central 
dopaminergic mechanisms in piribedil and clonidine 
induced hypothermia in the rat. Neuropharmacol. 14: 
215-220, 1975. 
Rochette, L., Bralet, A.M. and Bralet, J.: Effect of 
clonidine on the synthesis and release of noradrenaline 
in various regions of the rat brain. J. Pharmacol. 5: 
209-220, 1974. 
Rochette, L. and Bralet, J.: Effect of the norepinephrine 
receptor stimulating agent "clonidine" on the turn-
over of 5-hydroxytryptamine in some areas of rat 
brain. J. Neural Trans. 37: 259-267, 1975. 
Ruiz, M. and Monti, J.M.: Reversal of the 6-hydroxydopa-
mine-induced suppression of CAR by drugs facilitating 
central catecholaminergic mechanism. Pharmacol. 13: 
281-286, 1975. 
Saperia, J.: Clonidine overdose. Brit. Med. J. 4: 580, 
19 75. 
Sastry, B.S.R. and Phyllis, J.W.: Evidence that clonidine 
can activate histamine H2-receptors in rat cerebral 
cortex. Neuropharmacol. 16: 223-225, 1977. 
Satoh, H., Satoh, Y., Notsu, Y. and Honda, F.: Adenosine 
3',5'-cyclic monophsophate as a possible mediator of 
rotational behavior induced by dopaminergic receptor 
stimulation in rats lesioned unilaterally in the 
substania nigra. Eur. J. Pharrnacol. 39: 365-377, 1976. 
Scheel-Kruger, J. and Hasselager, E.: Studies of various 
amphetamines, apomorphine and clonidine on body 
temperature and brain 5-hydroxytryptamine metabolism 
in rats. Psychopharmacologia 36: 189-202, 1974. 
Schmitt, H. and Schmitt, H.: Interaction between 2-
(2,6-dichlorophenylamino)-2-imidazoline hydrochloride 
(ST 155, Catapressan), and alpha-adrenergic blocking 
drugs. Eur. J. Pharmacol. 9: 7-13, 1970. 
127 
Schmitt, H., Le Douarec, J.C., and Petillot, N.: Anti-
nociceptive effects of some alpha-sympathomimetic 
agents. Neuropharmacol. 13: 289-294, 1974. 
Schuster, C.R.: Variables affecting the self-administra-
tion of drugs by rhesus monkeys. In: Use of Nonhuman 
primates in Drug Evaluation. Edited by H. Vagtborg 
pp 283-296 , University of Texas Press, Austin, 
1968. 
Seiden, L.S. and Dykstra, L.A.: Psychopharmacology: 
A Biochemical and Behavioral Approach. Van Nostrand 
Reinhold Co., New York, 1977. 
Shaw, S.G. and Rolls, E.T.: Is the release of noradren-
aline necessary for self-stimulation of the brain. 
Pharmacol. Biochem. Behav. 4: 375-379, 1976. 
Shearman, G., Hynes, M., Fielding, S. and Lal, H.: Cloni-
dine self-administration in the rat: a comparison with 
fentanyl self-administration. Pharmacologist, 19: 
171, 1977. 
Sewell, R.D.E. and Spencer, P.S.J.: Antinociceptive activity 
in mice after central injections of alpha- and beta-
adLenoceptor antagonists. Brit. J. Pharmacol. 54: 
256-257, 1975. 
Skolnick, P. and Daly, J.W.: Stimulation of adenosine 
3',5'-monophosphate formation by alpha and beta 
adrenergic agonists in rat cerebral cortical slices: 
effects of clonidine. Malec. Pharmacol. 11: 545-551, 
1975a. 
Skolnick, P. and Daly, J.: Stimulation of adenosine 3', 
5'-monophosphate formation in rat cerebral cortical 
slices by methoxamine: interaction with an alpha 
adrenergic receptor. J. Pharmacol. Exp. Ther. 193: 
549-558, 1975b. 
Skolnick, P. and Daly, J.W.: Interaction of clonidine with 
pre- and post-synaptic adrenergic recptors of rat 
brain: effects on cyclic-AMP generating system. 
Eur. J. Pharmacol. 39: 11-21, 1976. 
Smith, W.M. Jr.: Nalorphine as an aversive agent. Proc. 
8lst Ann. Con. Psychol. Assoc. 1053-1054, 1973. 
Smith, S.G. and Davis, W.M.: Haloperidol effects on 
morphine self-administration: testing for pharmacolog-
ical modification of the primary reinforcement 
mechanism. Psychol. Rec. 23: 215-221, 1973. 
128 
Smith, S.G. and Davis, W.M.: A method for chronic intra-
venous drug administration in the rat. In: Methods 
in Narcotic Research. Ed. S. Ehrenpreis and A. Neidle 
pp. 3-32, Marcel Dekker, Inc., New York, 1975. 
Spaulding, T.S., Venafro, J., Ma, M., Cornfeldt, M. and 
Fielding, S.: Interaction of morphine and clonidine 
in the tail flick test: potentiation studies. 
Pharmacologist, 20: 269, 1978. 
Spealman, R.D. and Goldberg, S.R.: Drug self-administra-
tion by laboratory animals: control by schedules of 
£einforcement. Ann. Rev. Pharmacol. Toxicol. 18: 
313-339, 1978. 
Spencer, J. and Revzin, A.: Amphetamine, chlorpromazine 
and clonidine effects on self-stimulation in caudate 
or hypothalamus of the squirrel monkey. Pharmacol. 
Biochem. Behav. 5: 149-156, 1976. 
Starke, K. and Montel, H.: Involvement of alpha-receptors 
in clonidine-induced inhibition of transmitter release 
from central monoamine neurones. Neuropharmacol 12: 
1073-1080, 1973. 
Stern, P. and Catovic, S.: 
behavior. Pharmacol. 
1975. 
Brain glycine and aggressive 
Biochem. Behav. 3: 723-726, 
Stricker, E.M. and Zigmond, M.J.: Recovery of function 
following damage to central catecholamine-containing 
neurons: a neurochemical model of the lateral hypo-
thalamic syndrome. In: Progress in Psychobiology and 
Physiological Psychology, edited by J.M. Sprague 
and A.N. Epstein, Academic Press, New York, 1976. 
Strombom, U.: 
on motor 
in mouse 
167-176, 
Catecholamine receptor agonists. Effects 
activity and rate of tyrosine hydroxylation 
brain. Naunyn-Schmied. Arch. Pharmacol. 292: 
1976. 
Svensson, T.H., Burrey, B.S. and Aghajanian, G.K.: Inhi-
bition of both noradrenergic and serotonergic neurons 
in the brain by the alpha-adrenergic agonist clonidine. 
Brain Res. 92: 291-306, 1975. 
Thompson, T. and Schuster, C.R.: Morphine self-administra-
tion, food-reinforced, and avoidance behaviors in rhesus 
monkeys. Psychopharmacologia 5: 87-94, 1964. 
Thompson, T. and Pickens, R.: Stimulant self-administration 
by animals: some comparisons with opiate self-adminis-
tration. Fed. Proc. 29: 6-12, 1970. 
129 
Tilson, H.A., Chamberlain, J.H., Gylys, J.A. and Buyniski, 
J.P.: Behavioral suppressant effects of clonidine 
in strains of normotensive and hypertensive rats. 
Eur. Pharmacol. 43: 99-105, 1977. 
Tseng, L.F., Loh, H.H. and Wei, E.T.: Effect of clonidine 
on morphine withdrawal signs in the rat. Eur. J. 
Pharmacol. 30: 93-99, 1975. 
Tsoucaris-Kupfer, D. and Schmitt, H.: Hypothermic effect 
of alpha-sympathomimetic agents and their antagonism 
by adrenergic and cholinergic blocking drugs. Neuro-
pharmacol. 11: 625-635, 1972. 
Ungerstedt, U., Butcher, L.L., Butcher, S.G., Anden, N.E. 
and Fuxe, K.: Direct chemical stimulation of dop-
aminergic mechanism in the neostriaturn of the rat. 
Brain Res. 14: 461-468, 1969. 
Van Zwieten, P.A.: Antihypertensive drugs with a central 
action. Prog. Pharrnacol. 1: 1-63, 1975. 
vetulani, J. and Bednarczyk, B.: 
of shaking behavior elicited 
morphine-dependent rats. J. 
567-568, 1977. 
Depression by clonidine 
by nalorphine in 
Pharm. Pharmacol. 29: 
Vetulani, J., Leith, N.J., Stawarz, R.J. and Sulser, F.: 
Effect of clonidine on the noradrenergic cyclic AMP 
generating system in the limbic forebrain and on 
medial forebrain self-stimulation behavior. Experientia 
33: 1490-1491, 1977. 
Walland, A.: Clonidine. In: Pharmacological and Biochemi-
cal Properties of Drug Substances, edited by M.E. 
Goldberg pp. 67-107 , American Pharmaceutical 
Association, Washington, D.C., 1977. 
Washton, A.M., Resnick, R.B. and LaPlaca, R.A.: Clonidine 
hydrochloride: a non-opiate treatment for opiate 
withdrawal. Abstract ACNP, 1978. 
Weeks, J.R.: Experimental morphine addiction: method for 
automatic intravenous injections in unrestrained 
rats. Science 138: 143-144, 1962. 
Weeks, J.R. and Collins, R.J.: Factors affecting voluntary 
morphine intake in self-maintained addicted rats. 
Science 138: 143-144,1964. 
Wei, E., Tseng, L.F., Loh, H.H. and Way, E.L.: Morphine 
abstinence signs: similarity to thermoregulatory 
behavior. Nature 247: 398-400, 1974. 
130 
Wei, E.: Resemblance of morphine antinociception to the 
central depressant actions of norepinephrine. Life 
Sci. 17: 17-18, 1975. 
Wei, E.: Chemical stimulants of shaking behavior. J. 
Pharm. Pharmacol. 28: 722-723, 1976. 
Wendt, F. and Caspers, I.: Kopperternperateur und Schweiss-
sekretion vei Kopenlicker Belastung unter dem Einflurs 
von 2-(2,6-dichlorophenylamino)-2-imidazolin hydro-
chlorid. In: Hochdruck-Therapie, Symposium uber 
2(2,6-dichlorophenylamino)-2-imidazolin hydrochlorid, 
edited by L. Heilmeyer, H.J. Holtmeier and E.F. 
Pfeiffer, Stuggart, George Thieme, 1968. 
Wilson, M.C. and Schuster, C.R.: The effects of chlorproma-
zine on psychomotor stimulant self-administration in 
the rhesus monkey. Psychopharmacologia 26: 115-126, 
1972. 
Wilson, M.C. and Schuster, C.R.: Aminergic influences on 
intravenous cocaine self-administration by rhesus 
monkeys. Pharmacol. Biochem. Behav. 2: 563-571, 1974. 
Wing, L.M.H., Davies, D.S., Reid, J.L. and Dollery, C.T.: 
Clonidine overdose. Brit. Med. J. 4: 408-409, 1975. 
Winger, G., Stitzer, M.L. and Woods, J.H.: Barbiturate-
reinforced responding in rhesus monkeys: comparisons 
of drugs with different durations of action. J. 
Pharmacol. Exp. Ther. 195: 505-514, 1975. 
Wise, C.D., Berger, B.P. and Stein, L.: Evidence of alpha-
noradrenergic reward receptors and serotonergic punish-
ment receptors in the rat brain. Biol. Psychiat. 6: 
3-11, 1973. 
Wise, R.A.: Neuroletpic attenuation of intracranial self-
stimulation: reward or performance deficits? Life 
Sci. 22: 535-542, 1978. 
Woods, J.H. and Schuster, C.R.: Reinforcement properties 
of morphine, cocaine and SPA as a function of unit dose. 
Int. J. Addictions 3: 231-237, 1968. 
woods, J.H. and Villarreal, J.E.: Patterns of cocaine-, 
codeine, and pentazocine-reinforced responding in 
the rhesus monkey. Pharmacologist 12: 230, 1970. 
131 
I 
Woods, J.H. and Schuster, C.R.: Opiates as reinforcing 
stimuli. In: Stimulus Properties of Drugs, edited 
by T. Thompson and R.Pickens, pp 163-175', Appleton-
Century-Crofts, New York, 1971. 
Woods, J.H., Downs, D.A. and Carney, J.: Behavioral 
functions of narcotic antagonists: response-drug 
contingencies. Federation Proceedings 34: 1777-
1784, 1975. 
Yokel, R.A. and Wise, R.A.: Increased lever pressing for 
amphetamine after pimozide in rats: Implications 
for a dopamine theory of reward. Science 187: 547-549, 
1975. 
Yokel, R.A. and Wise, R.A.: Attenuation of intravenous 
amphetamine reinforcement by centraldopamine blockade 
in rats. Psychopharmacology 48: 311-318, 1976. 
Zamis, E.: The pharmacology of Catapress (ST 155). In 
Catapres in Hypertension, edited by M.E. Conolly, 
pp. 9-22 , Buterworth, London, 1970. 
132 
